Gene	O
bi	O
-	O
targeting	O
by	O
viral	O
and	O
human	B-OG
miRNAs	O

Background	O

MicroRNAs	O
(	O
miRNAs	O
)	O
are	O
an	O
abundant	O
class	O
of	O
small	O
noncoding	O
RNAs	O
(	O
20	O
-	O
24	O
nts	O
)	O
that	O
can	O
affect	O
gene	O
expression	O
by	O
post	O
-	O
transcriptional	O
regulation	O
of	O
mRNAs	O
.	O

They	O
play	O
important	O
roles	O
in	O
several	O
biological	O
processes	O
(	O
e	O
.	O
g	O
.,	O
development	O
and	O
cell	O
cycle	O
regulation	O
).	O

Numerous	O
bioinformatics	O
methods	O
have	O
been	O
developed	O
to	O
identify	O
the	O
function	O
of	O
miRNAs	O
by	O
predicting	O
their	O
target	O
mRNAs	O
.	O

Some	O
viral	O
organisms	O
also	O
encode	O
miRNAs	O
,	O
a	O
fact	O
that	O
contributes	O
to	O
the	O
complex	O
interactions	O
between	O
viruses	B-OG
and	O
their	O
hosts	O
.	O

A	O
need	O
arises	O
to	O
understand	O
the	O
functional	O
relationship	O
between	O
viral	O
and	O
host	O
miRNAs	O
and	O
their	O
effect	O
on	O
viral	O
and	O
host	O
genes	O
.	O

Our	O
approach	O
to	O
meet	O
this	O
challenge	O
is	O
to	O
identify	O
modules	O
where	O
viral	O
and	O
host	O
miRNAs	O
cooperatively	O
regulate	O
host	O
gene	O
expression	O
.	O

Results	O

We	O
present	O
a	O
method	O
to	O
identify	O
groups	O
of	O
viral	O
and	O
host	O
miRNAs	O
that	O
cooperate	O
in	O
post	O
-	O
transcriptional	O
gene	O
regulation	O
,	O
and	O
their	O
target	O
genes	O
that	O
are	O
involved	O
in	O
similar	O
biological	O
processes	O
.	O

We	O
call	O
these	O
groups	O
(	O
genes	O
and	O
miRNAs	O
of	O
human	B-OG
and	O
viral	O
origin	O
)	O
-	O
modules	O
.	O

The	O
modules	O
are	O
found	O
in	O
a	O
new	O
two	O
-	O
stage	O
procedure	O
,	O
which	O
we	O
call	O
bi	O
-	O
targeting	O
,	O
and	O
is	O
presented	O
in	O
this	O
paper	O
.	O

The	O
stages	O
are	O
(	O
i	O
)	O
a	O
new	O
and	O
efficient	O
target	O
prediction	O
,	O
and	O
(	O
ii	O
)	O
a	O
new	O
method	O
for	O
clustering	O
objects	O
of	O
three	O
different	O
data	O
types	O
.	O

In	O
this	O
work	O
we	O
integrate	O
multiple	O
information	O
sources	O
,	O
including	O
miRNA	O
-	O
target	O
binding	O
information	O
,	O
miRNA	O
expression	O
profiles	O
,	O
and	O
GO	O
annotations	O
.	O

Our	O
hypotheses	O
and	O
the	O
methods	O
have	O
been	O
tested	O
on	O
human	B-OG
and	O
Epstein	B-OG
Barr	I-OG
virus	I-OG
(	O
EBV	B-OG
)	O
miRNAs	O
and	O
human	B-OG
genes	O
,	O
for	O
which	O
we	O
found	O
34	O
modules	O
.	O

We	O
provide	O
supporting	O
evidence	O
from	O
biological	O
and	O
medical	O
literature	O
for	O
two	O
of	O
our	O
modules	O
.	O

Our	O
code	O
and	O
data	O
are	O
available	O
at	O
http	O
://	O
www	O
.	O
cs	O
.	O
bgu	O
.	O
ac	O
.	O
il	O
/~	O
vaksler	O
/	O
BiTargeting	O
.	O
htm	O

Conclusions	O

The	O
presented	O
algorithm	O
,	O
which	O
makes	O
use	O
of	O
diverse	O
biological	O
data	O
,	O
is	O
demonstrated	O
to	O
be	O
an	O
efficient	O
approach	O
for	O
finding	O
bi	O
-	O
targeting	O
modules	O
of	O
viral	O
and	O
human	B-OG
miRNAs	O
.	O

These	O
modules	O
can	O
contribute	O
to	O
a	O
better	O
understanding	O
of	O
viral	O
-	O
host	O
interactions	O
and	O
the	O
role	O
that	O
miRNAs	O
play	O
in	O
them	O
.	O

Background	O

MicroRNAs	O
(	O
miRNAs	O
)	O
are	O
an	O
abundant	O
class	O
of	O
small	O
noncoding	O
RNAs	O
(	O
20	O
-	O
24	O
nts	O
)	O
that	O
can	O
affect	O
gene	O
expression	O
by	O
post	O
-	O
transcriptional	O
regulation	O
of	O
mRNAs	O
[	O
1	O
].	O

They	O
typically	O
base	O
pair	O
with	O
sequences	O
in	O
the	O
3	O
'	O
UTR	O
of	O
mRNAs	O
to	O
inhibit	O
mRNA	O
translation	O
or	O
to	O
promote	O
their	O
degradation	O
.	O

miRNAs	O
have	O
been	O
shown	O
to	O
play	O
important	O
roles	O
in	O
various	O
cellular	O
and	O
pathogenic	O
processes	O
,	O
including	O
development	O
,	O
cell	O
death	O
,	O
immunological	O
response	O
,	O
and	O
carcinogenesis	O
[	O
2	O
,	O
3	O
].	O

Since	O
the	O
functional	O
characterization	O
of	O
miRNAs	O
depends	O
heavily	O
on	O
identification	O
of	O
their	O
specific	O
target	O
mRNAs	O
,	O
numerous	O
bioinformatics	O
methods	O
have	O
been	O
developed	O
for	O
this	O
task	O
(	O
see	O
e	O
.	O
g	O
.,	O
[	O
4	O
-	O
11	O
],	O
for	O
a	O
review	O
see	O
[	O
12	O
-	O
14	O
]).	O

In	O
recent	O
years	O
,	O
it	O
has	O
been	O
shown	O
that	O
viruses	B-OG
also	O
encode	O
miRNAs	O
[	O
15	O
,	O
16	O
].	O

Although	O
for	O
most	O
of	O
the	O
viral	O
miRNAs	O
no	O
functions	O
have	O
yet	O
been	O
described	O
,	O
it	O
is	O
conjectured	O
that	O
these	O
miRNAs	O
also	O
take	O
part	O
in	O
the	O
complex	O
interactions	O
between	O
viruses	B-OG
and	O
their	O
hosts	O
,	O
and	O
several	O
scenarios	O
have	O
been	O
proposed	O
[	O
17	O
]	O
(	O
see	O
Figure	O
1	O
,	O
where	O
scenario	O
numbers	O
are	O
written	O
in	O
rhombi	O
).	O

In	O
the	O
first	O
scenario	O
,	O
viral	O
miRNAs	O
regulate	O
viral	O
gene	O
expression	O
for	O
maintaining	O
,	O
e	O
.	O
g	O
.,	O
replication	O
,	O
latency	O
,	O
or	O
evading	O
the	O
host	O
-	O
immune	O
system	O
.	O

For	O
example	O
,	O
miR	O
-	O
BART2	O
of	O
EBV	B-OG
exhibits	O
perfect	O
complementarity	O
to	O
the	O
3	O
'	O
UTR	O
of	O
BALF5	B-GP
,	O
which	O
encodes	O
the	O
viral	O
DNA	B-GP
polymerase	I-GP
[	O
18	O
],	O
and	O
such	O
an	O
interaction	O
might	O
be	O
essential	O
for	O
maintaining	O
EBV	B-OG
latency	O
.	O

In	O
the	O
second	O
scenario	O
,	O
host	O
miRNAs	O
interact	O
with	O
viral	O
RNAs	O
,	O
thereby	O
inhibiting	O
virus	B-OG
replication	O
,	O
e	O
.	O
g	O
.,	O
miR	O
-	O
32	O
can	O
limit	O
the	O
replication	O
of	O
the	O
retrovirus	B-OG
primate	B-OG
foamy	I-OG
virus	I-OG
(	O
PFV	B-OG
)	O
in	O
cell	O
culture	O
through	O
an	O
interaction	O
with	O
PFV	B-OG
mRNAs	O
[	O
19	O
].	O

In	O
the	O
third	O
scenario	O
,	O
viral	O
miRNAs	O
regulate	O
host	O
genes	O
to	O
induce	O
a	O
more	O
favorable	O
environment	O
for	O
the	O
virus	B-OG
.	O

The	O
regulated	O
genes	O
are	O
most	O
likely	O
related	O
to	O
antiviral	O
response	O
,	O
apoptosis	O
,	O
interferon	B-GP
system	O
,	O
signal	O
transduction	O
,	O
or	O
cellular	O
proliferation	O
[	O
20	O
,	O
21	O
].	O

Stern	O
-	O
Ginossar	O
et	O
al	O
.	O
[	O
22	O
]	O
showed	O
that	O
human	B-OG
cytomegalovirus	I-OG
(	O
HCMV	B-OG
)	O
miRNA	O
,	O
miR	O
-	O
UL112	O
,	O
inhibits	O
the	O
translation	O
of	O
a	O
cellular	O
gene	O
MICB	B-GP
,	O
which	O
is	O
normally	O
activated	O
when	O
cells	O
are	O
subjected	O
to	O
severe	O
stress	O
,	O
such	O
as	O
viral	B-DS
infection	I-DS
.	O

MICB	B-GP
marks	O
these	O
cells	O
for	O
destruction	O
by	O
natural	O
killer	O
cells	O
.	O

The	O
resulting	O
absence	O
of	O
MICB	B-GP
protein	O
protects	O
HCMV	B-OG
-	O
infected	O
cells	O
against	O
lysis	O
by	O
natural	O
killer	O
cells	O
.	O

Four	O
scenarios	O
for	O
miRNA	O
involvement	O
in	O
host	O
-	O
virus	B-OG
interactions	O
.	O

(	O
1	O
)	O
Viral	O
miRNAs	O
inhibit	O
the	O
expression	O
of	O
viral	O
mRNAs	O
.	O

(	O
2	O
)	O
Host	O
miRNAs	O
inhibit	O
the	O
expression	O
of	O
viral	O
mRNAs	O
.	O

(	O
3	O
)	O
Viral	O
miRNAs	O
inhibit	O
the	O
expression	O
of	O
host	O
mRNAs	O
.	O

(	O
4	O
)	O
Host	O
miRNAs	O
inhibit	O
the	O
expression	O
of	O
host	O
mRNAs	O
.	O

In	O
this	O
case	O
,	O
viruses	B-OG
may	O
regulate	O
host	O
miRNA	O
expression	O
and	O
indirectly	O
regulate	O
host	O
gene	O
expression	O
.	O

(	O
This	O
figure	O
is	O
partially	O
adapted	O
from	O
[	O
81	O
].)	O

Viruses	B-OG
may	O
affect	O
host	O
miRNAs	O
for	O
their	O
own	O
advantage	O
,	O
by	O
regulating	O
up	O
or	O
down	O
the	O
expression	O
of	O
these	O
miRNAs	O
.	O

This	O
happens	O
in	O
the	O
fourth	O
scenario	O
reported	O
in	O
[	O
23	O
].	O

In	O
their	O
research	O
,	O
host	O
miR	O
-	O
17	O
and	O
miR	O
-	O
20a	O
were	O
found	O
to	O
be	O
downregulated	O
following	O
human	B-OG
immunodeficiency	I-OG
virus	I-OG
(	B-DS
HIV	I-DS
-	I-DS
1	I-DS
)	I-DS
infection	I-DS
.	O

These	O
miRNAs	O
target	O
the	O
3	O
'	O
UTR	O
of	O
host	O
gene	O
PCAF	B-GP
,	O
which	O
has	O
been	O
proposed	O
to	O
promote	O
HIV	B-OG
-	I-OG
1	I-OG
transcriptional	O
elongation	O
.	O

Hence	O
,	O
this	O
downregulation	O
is	O
needed	O
for	O
efficient	O
replication	O
of	O
the	O
virus	B-OG
.	O

In	O
our	O
work	O
we	O
will	O
examine	O
the	O
combination	O
of	O
the	O
last	O
two	O
scenarios	O
,	O
assuming	O
that	O
both	O
human	B-OG
and	O
viral	O
miRNAs	O
play	O
an	O
active	O
role	O
in	O
regulating	O
genes	O
that	O
either	O
promote	O
or	O
inhibit	O
viral	O
replication	O
or	O
life	O
cycle	O
.	O

Cooperativity	O
of	O
miRNAs	O
in	O
gene	O
regulation	O

Previous	O
studies	O
show	O
that	O
one	O
miRNA	O
may	O
have	O
several	O
target	O
genes	O
.	O

Furthermore	O
,	O
one	O
mRNA	O
can	O
be	O
targeted	O
by	O
multiple	O
miRNAs	O
,	O
reflecting	O
cooperative	O
translational	O
control	O
[	O
5	O
,	O
24	O
,	O
25	O
].	O

Experimental	O
evidence	O
indicates	O
that	O
multiple	O
target	O
sites	O
(	O
of	O
one	O
or	O
more	O
miRNAs	O
)	O
in	O
the	O
same	O
3	O
'	O
UTR	O
can	O
potentially	O
increase	O
the	O
degree	O
of	O
translational	O
repression	O
[	O
9	O
].	O

In	O
addition	O
,	O
microarray	O
analyses	O
[	O
26	O
]	O
reveal	O
that	O
most	O
of	O
the	O
miRNAs	O
only	O
modestly	O
affect	O
their	O
mRNA	O
targets	O
.	O

Recent	O
findings	O
show	O
that	O
some	O
virus	B-OG
encoded	O
miRNAs	O
have	O
sequence	O
homology	O
to	O
their	O
host	O
human	B-OG
/	O
mouse	B-OG
miRNAs	O
,	O
mainly	O
in	O
the	O
seed	O
region	O
(	O
see	O
review	O
[	O
21	O
]).	O

This	O
is	O
one	O
of	O
many	O
mechanisms	O
that	O
are	O
used	O
by	O
viruses	B-OG
to	O
exploit	O
their	O
host	O
[	O
27	O
-	O
30	O
].	O

We	O
were	O
intrigued	O
by	O
an	O
additional	O
possibility	O
in	O
which	O
viral	O
and	O
host	O
encoded	O
miRNAs	O
target	O
the	O
same	O
mRNA	O
,	O
possibly	O
in	O
different	O
target	O
sites	O
,	O
to	O
promote	O
gene	O
silencing	O
.	O

It	O
would	O
make	O
sense	O
that	O
viral	O
miRNAs	O
that	O
share	O
targets	O
with	O
human	B-OG
miRNAs	O
may	O
contribute	O
to	O
increasing	O
the	O
translational	O
repression	O
and	O
tighten	O
the	O
regulation	O
which	O
already	O
exists	O
at	O
a	O
low	O
level	O
in	O
the	O
cell	O
(	O
by	O
the	O
host	O
regulation	O
machinery	O
).	O

This	O
important	O
question	O
motivated	O
us	O
to	O
study	O
and	O
predict	O
the	O
cooperativity	O
of	O
viral	O
and	O
host	O
miRNAs	O
on	O
host	O
genes	O
.	O

In	O
this	O
paper	O
,	O
we	O
present	O
a	O
new	O
computational	O
method	O
for	O
examining	O
cooperative	O
effects	O
of	O
viral	O
and	O
host	O
miRNAs	O
on	O
the	O
regulation	O
of	O
host	O
genes	O
.	O

We	O
find	O
modules	O
consisting	O
of	O
both	O
viral	O
and	O
human	B-OG
miRNAs	O
,	O
and	O
their	O
common	O
target	O
genes	O
,	O
that	O
are	O
involved	O
in	O
similar	O
biological	O
processes	O
(	O
according	O
to	O
GO	O
).	O

The	O
mathematical	O
formulation	O
of	O
our	O
problem	O
is	O
an	O
extension	O
of	O
a	O
related	O
problem	O
,	O
where	O
the	O
sought	O
modules	O
consist	O
of	O
miRNAs	O
and	O
genes	O
of	O
the	O
same	O
species	O
.	O

Below	O
we	O
present	O
some	O
studies	O
that	O
worked	O
to	O
solve	O
the	O
latter	O
problem	O
.	O

Yoon	O
and	O
De	O
Micheli	O
[	O
31	O
],	O
the	O
first	O
to	O
address	O
that	O
problem	O
,	O
represent	O
the	O
multiple	O
relations	O
between	O
miRNAs	O
and	O
target	O
genes	O
by	O
a	O
weighted	O
bipartite	O
graph	O
,	O
and	O
find	O
bi	O
-	O
cliques	O
in	O
the	O
graph	O
that	O
represent	O
the	O
miRNA	O
-	O
mRNA	O
modules	O
(	O
see	O
Figure	O
2	O
).	O

They	O
predict	O
modules	O
using	O
target	O
prediction	O
based	O
on	O
sequence	O
information	O
.	O

Bipartite	O
graph	O
.	O

Bi	O
-	O
cliques	O
in	O
the	O
graph	O
are	O
circled	O
.	O

Two	O
other	O
approaches	O
combine	O
several	O
information	O
sources	O
to	O
extract	O
the	O
modules	O
,	O
including	O
predictions	O
of	O
miRNA	O
target	O
genes	O
and	O
their	O
respective	O
expression	O
profiles	O
.	O

Joung	O
et	O
al	O
.	O
[	O
32	O
]	O
apply	O
a	O
genetic	O
algorithm	O
,	O
based	O
on	O
coevolutionary	O
learning	O
,	O
to	O
find	O
an	O
optimal	O
miRNA	O
-	O
mRNA	O
module	O
.	O

Tran	O
et	O
al	O
.	O
[	O
33	O
]	O
use	O
a	O
rule	O
-	O
based	O
learning	O
method	O
to	O
identify	O
the	O
modules	O
.	O

In	O
general	O
,	O
finding	O
bi	O
-	O
cliques	O
in	O
bi	O
-	O
partite	O
graphs	O
can	O
be	O
formulated	O
as	O
a	O
bi	O
-	O
clustering	O
problem	O
(	O
reviewed	O
in	O
[	O
34	O
]),	O
which	O
is	O
known	O
to	O
be	O
NP	O
-	O
complete	O
.	O

Therefore	O
,	O
most	O
of	O
the	O
methods	O
that	O
address	O
bi	O
-	O
clustering	O
are	O
based	O
on	O
heuristic	O
approaches	O
,	O
which	O
may	O
miss	O
good	O
solutions	O
.	O

Alternatively	O
,	O
applying	O
naive	O
exhaustive	O
enumeration	O
to	O
this	O
problem	O
is	O
extremely	O
time	O
consuming	O
to	O
the	O
point	O
of	O
being	O
impractical	O
.	O

The	O
problem	O
becomes	O
even	O
more	O
complicated	O
when	O
searching	O
for	O
cooperative	O
human	B-OG
-	O
viral	O
miRNA	O
modules	O
.	O

Directly	O
applying	O
one	O
of	O
the	O
existing	O
bi	O
-	O
clustering	O
algorithms	O
to	O
a	O
united	O
set	O
of	O
both	O
human	B-OG
and	O
viral	O
miRNAs	O
may	O
be	O
insensitive	O
to	O
the	O
contribution	O
of	O
viral	O
miRNAs	O
.	O

This	O
is	O
due	O
to	O
the	O
wide	O
imbalance	O
between	O
the	O
numbers	O
of	O
human	B-OG
miRNAs	O
and	O
viral	O
miRNAs	O
(	O
hundreds	O
of	O
human	B-OG
miRNAs	O
versus	O
tens	O
of	O
viral	O
miRNAs	O
identified	O
to	O
date	O
).	O

In	O
order	O
to	O
be	O
able	O
to	O
control	O
the	O
composition	O
of	O
the	O
sought	O
modules	O
in	O
terms	O
of	O
viral	O
and	O
human	B-OG
miRNA	O
participants	O
,	O
a	O
new	O
type	O
of	O
clustering	O
algorithm	O
is	O
needed	O
.	O

And	O
indeed	O
,	O
in	O
this	O
paper	O
we	O
describe	O
a	O
bi	O
-	O
targeting	O
algorithm	O
which	O
we	O
developed	O
(	O
see	O
Methods	O
).	O

We	O
apply	O
a	O
branch	O
and	O
bound	O
approach	O
to	O
develop	O
and	O
prune	O
an	O
enumeration	O
tree	O
of	O
groups	O
of	O
human	B-OG
genes	O
that	O
are	O
targeted	O
by	O
the	O
same	O
set	O
of	O
viral	O
and	O
human	B-OG
miRNAs	O
.	O

This	O
algorithm	O
is	O
very	O
efficient	O
since	O
we	O
exploit	O
the	O
fact	O
that	O
the	O
number	O
of	O
known	O
viral	O
miRNAs	O
is	O
relatively	O
small	O
,	O
and	O
that	O
we	O
demand	O
a	O
quorum	O
on	O
the	O
number	O
of	O
miRNAs	O
in	O
the	O
modules	O
(	O
a	O
minimum	O
number	O
of	O
viral	O
and	O
human	B-OG
miRNAs	O
).	O

This	O
""""	O
pruning	O
by	O
quorum	O
""""	O
allows	O
us	O
to	O
apply	O
enumeration	O
in	O
practical	O
run	O
time	O
.	O

We	O
implemented	O
our	O
bi	O
-	O
targeting	O
algorithm	O
into	O
a	O
software	O
system	O
that	O
combines	O
a	O
variety	O
of	O
biological	O
data	O
sources	O
,	O
such	O
as	O
:	O
genomic	O
sequences	O
,	O
miRNA	O
expression	O
measurements	O
,	O
GO	O
annotations	O
,	O
and	O
tissue	O
context	O
.	O

The	O
combination	O
of	O
several	O
information	O
sources	O
in	O
the	O
task	O
of	O
module	O
detection	O
minimizes	O
noise	O
and	O
errors	O
accompanying	O
each	O
information	O
source	O
,	O
resulting	O
in	O
more	O
accurate	O
results	O
.	O

In	O
addition	O
,	O
we	O
developed	O
a	O
very	O
flexible	O
and	O
efficient	O
target	O
prediction	O
algorithm	O
,	O
which	O
we	O
briefly	O
describe	O
in	O
the	O
next	O
section	O
,	O
and	O
in	O
more	O
detail	O
in	O
the	O
Appendix	O
Section	O
.	O

We	O
use	O
it	O
as	O
a	O
preprocessing	O
step	O
to	O
the	O
module	O
search	O
.	O

Using	O
the	O
bi	O
-	O
targeting	O
system	O
,	O
we	O
study	O
the	O
cooperative	O
regulation	O
of	O
human	B-OG
and	O
Epstein	B-OG
Barr	I-OG
Virus	I-OG
(	O
EBV	B-OG
)	O
miRNAs	O
on	O
human	B-OG
mRNAs	O
in	O
various	O
lymphomas	B-DS
related	O
to	O
EBV	B-OG
.	O

The	O
significant	O
modules	O
are	O
picked	O
by	O
a	O
sampling	O
procedure	O
(	O
described	O
in	O
the	O
next	O
section	O
).	O

We	O
validate	O
two	O
of	O
these	O
modules	O
by	O
surveying	O
information	O
from	O
the	O
biological	O
and	O
biomedical	O
literature	O
.	O

The	O
rest	O
of	O
the	O
significant	O
modules	O
can	O
be	O
found	O
at	O
http	O
://	O
www	O
.	O
cs	O
.	O
bgu	O
.	O
ac	O
.	O
il	O
/~	O
vaksler	O
/	O
BiTargeting	O
.	O
htm	O
.	O

We	O
believe	O
that	O
the	O
results	O
of	O
this	O
research	O
may	O
have	O
far	O
-	O
reaching	O
implications	O
,	O
as	O
they	O
may	O
be	O
applied	O
to	O
the	O
diagnosis	O
and	O
treatment	O
of	O
viral	B-DS
infections	I-DS
,	O
as	O
well	O
as	O
for	O
a	O
wider	O
understanding	O
of	O
viral	O
-	O
induced	O
diseases	O
and	O
the	O
role	O
that	O
miRNAs	O
plays	O
in	O
them	O
.	O

Our	O
study	O
can	O
contribute	O
to	O
the	O
discovery	O
of	O
genes	O
that	O
regulate	O
virus	B-OG
-	O
host	O
interactions	O
,	O
especially	O
,	O
but	O
not	O
only	O
,	O
in	O
chronic	B-DS
infections	I-DS
,	O
and	O
can	O
serve	O
as	O
targets	O
for	O
therapy	O
[	O
35	O
,	O
36	O
].	O

Methods	O

Our	O
method	O
consists	O
of	O
two	O
stages	O
:	O
a	O
target	O
prediction	O
stage	O
and	O
a	O
module	O
search	O
stage	O
.	O

In	O
the	O
first	O
stage	O
,	O
we	O
perform	O
all	O
against	O
all	O
dynamic	O
programming	O
on	O
two	O
sets	O
of	O
sequences	O
(	O
miRNAs	O
and	O
mRNAs	O
)	O
in	O
order	O
to	O
predict	O
,	O
for	O
every	O
miRNA	O
in	O
the	O
set	O
,	O
its	O
target	O
mRNAs	O
.	O

In	O
the	O
second	O
stage	O
we	O
look	O
for	O
modules	O
that	O
are	O
enriched	O
in	O
some	O
biological	O
process	O
,	O
using	O
the	O
results	O
from	O
the	O
first	O
stage	O
and	O
information	O
from	O
Gene	O
Ontology	O
and	O
the	O
miRNA	O
Atlas	O
.	O

We	O
elaborate	O
more	O
on	O
the	O
second	O
stage	O
since	O
this	O
is	O
the	O
main	O
goal	O
of	O
our	O
paper	O
.	O

The	O
interested	O
reader	O
may	O
find	O
a	O
description	O
of	O
the	O
first	O
stage	O
in	O
the	O
Appendix	O
Section	O
.	O

Stage	O
1	O
-	O
Predicting	O
microRNA	O
targets	O

The	O
purpose	O
of	O
this	O
stage	O
is	O
to	O
perform	O
an	O
efficient	O
genome	O
-	O
wide	O
target	O
prediction	O
of	O
all	O
the	O
miRNAs	O
against	O
all	O
the	O
possible	O
subsequences	O
of	O
a	O
set	O
of	O
mRNAs	O
.	O

miRNA	O
target	O
prediction	O
is	O
a	O
well	O
-	O
studied	O
problem	O
,	O
with	O
numerous	O
tools	O
and	O
approaches	O
available	O
.	O

Each	O
of	O
these	O
tools	O
accommodates	O
a	O
variety	O
of	O
principles	O
and	O
features	O
of	O
target	O
recognition	O
,	O
for	O
example	O
typical	O
base	O
pairing	O
patterns	O
,	O
thermodynamic	O
analysis	O
of	O
the	O
miRNA	O
-	O
target	O
duplexes	O
,	O
conservation	O
of	O
the	O
target	O
site	O
among	O
related	O
species	O
,	O
and	O
accessibility	O
of	O
the	O
target	O
site	O
.	O

For	O
a	O
review	O
see	O
[	O
13	O
,	O
14	O
].	O

The	O
amount	O
of	O
the	O
data	O
we	O
need	O
to	O
analyze	O
is	O
huge	O
(	O
thousands	O
of	O
genes	O
and	O
hundreds	O
of	O
miRNAs	O
)	O
and	O
thus	O
applying	O
existing	O
tools	O
to	O
this	O
analysis	O
would	O
be	O
too	O
time	O
consuming	O
.	O

Hence	O
,	O
we	O
developed	O
our	O
own	O
efficient	O
tool	O
for	O
this	O
task	O
(	O
which	O
can	O
serve	O
as	O
a	O
plug	O
-	O
in	O
filter	O
to	O
other	O
target	O
prediction	O
tools	O
).	O

The	O
method	O
we	O
propose	O
extends	O
the	O
threshold	O
all	O
-	O
against	O
-	O
all	O
sequence	O
alignment	O
algorithm	O
[	O
37	O
,	O
38	O
].	O

We	O
store	O
the	O
miRNA	O
sequences	O
in	O
a	O
prefix	O
tree	O
(	O
trie	O
)	O
and	O
the	O
mRNA	O
sequences	O
in	O
a	O
separate	O
prefix	O
tree	O
(	O
for	O
details	O
see	O
the	O
Appendix	O
Section	O
).	O

We	O
then	O
apply	O
dynamic	O
programming	O
to	O
compute	O
hybridization	O
error	O
between	O
a	O
prefix	O
from	O
the	O
mRNA	O
tree	O
and	O
a	O
prefix	O
from	O
the	O
miRNA	O
tree	O
,	O
for	O
each	O
such	O
pair	O
.	O

If	O
,	O
in	O
one	O
comparison	O
,	O
the	O
number	O
of	O
errors	O
we	O
encounter	O
is	O
larger	O
than	O
a	O
given	O
threshold	O
,	O
then	O
we	O
stop	O
comparing	O
this	O
pair	O
and	O
its	O
descendants	O
in	O
the	O
respective	O
trees	O
(	O
prune	O
the	O
subtrees	O
).	O

Those	O
miRNA	O
-	O
target	O
pairs	O
that	O
survived	O
the	O
error	O
threshold	O
can	O
be	O
further	O
checked	O
for	O
duplex	O
energy	O
by	O
the	O
RNAduplex	O
program	O
[	O
39	O
].	O

This	O
results	O
in	O
linking	O
each	O
miRNA	O
in	O
our	O
data	O
set	O
to	O
its	O
predicted	O
target	O
genes	O
.	O

This	O
method	O
is	O
efficient	O
since	O
it	O
simultaneously	O
checks	O
sets	O
of	O
mRNA	O
sequences	O
(	O
and	O
,	O
respectively	O
,	O
miRNA	O
sequences	O
)	O
that	O
share	O
a	O
prefix	O
in	O
the	O
mRNA	O
(	O
respectively	O
,	O
miRNA	O
)	O
prefix	O
trees	O
.	O

Moreover	O
,	O
it	O
goes	O
over	O
all	O
the	O
duplexes	O
,	O
and	O
prunes	O
those	O
with	O
a	O
hybridization	O
error	O
above	O
a	O
threshold	O
,	O
allowing	O
a	O
very	O
efficient	O
filtration	O
.	O

Comparison	O
with	O
existing	O
approaches	O

We	O
compare	O
our	O
target	O
prediction	O
method	O
with	O
three	O
existing	O
tools	O
(	O
those	O
that	O
provide	O
downloadable	O
code	O
).	O

The	O
tools	O
are	O
miRanda	O
[	O
5	O
],	O
PITA	O
[	O
40	O
]	O
and	O
RNAhybrid	O
[	O
10	O
].	O

Our	O
dataset	O
consists	O
of	O
873	O
experimentally	O
validated	O
miRNA	O
-	O
gene	O
pairs	O
out	O
of	O
99	O
human	B-OG
miRNAs	O
and	O
640	O
mRNAs	O
(	O
from	O
miRecords	O
[	O
41	O
]).	O

We	O
downloaded	O
the	O
3	O
'	O
UTR	O
sequences	O
of	O
these	O
mRNAs	O
from	O
Ensembl	O
Biomart	O
[	O
42	O
],	O
a	O
total	O
of	O
2183	O
different	O
transcript	O
sequences	O
.	O

In	O
our	O
results	O
,	O
an	O
miRNA	O
-	O
mRNA	O
pair	O
is	O
considered	O
a	O
hit	O
if	O
the	O
miRNA	O
is	O
found	O
to	O
target	O
one	O
of	O
the	O
transcripts	O
of	O
the	O
mRNA	O
.	O

We	O
ran	O
our	O
target	O
prediction	O
method	O
with	O
the	O
constraints	O
listed	O
in	O
Table	O
1	O
.	O

miRanda	O
was	O
run	O
with	O
default	O
parameters	O
.	O

The	O
parameters	O
of	O
PITA	O
and	O
RNAhybrid	O
were	O
set	O
to	O
be	O
close	O
to	O
ours	O
(	O
seed	O
2	O
-	O
8	O
,	O
and	O
the	O
maximal	O
bulge	O
size	O
,	O
in	O
RNAhybrid	O
was	O
set	O
to	O
6	O
).	O

We	O
compare	O
the	O
results	O
of	O
these	O
four	O
methods	O
in	O
Table	O
2	O
.	O

The	O
information	O
which	O
we	O
compare	O
includes	O
:	O
the	O
total	O
number	O
of	O
predicted	O
pairs	O
,	O
the	O
number	O
of	O
TP	O
predicted	O
pairs	O
(	O
sensitivity	O
)	O
and	O
the	O
running	O
time	O
.	O

For	O
our	O
target	O
prediction	O
tool	O
,	O
the	O
total	O
number	O
of	O
predicted	O
pairs	O
falls	O
within	O
the	O
ballpark	O
of	O
both	O
PITA	O
and	O
miRanda	O
.	O

RNAhybrid	O
,	O
on	O
the	O
other	O
hand	O
,	O
predicts	O
twice	O
as	O
many	O
pairs	O
.	O

As	O
far	O
as	O
sensitivity	O
goes	O
,	O
our	O
results	O
pretty	O
much	O
match	O
that	O
of	O
PITA	O
and	O
outperforms	O
miRanda	O
by	O
far	O
.	O

RNAhybrid	O
gave	O
the	O
best	O
sensitivity	O
,	O
(	O
however	O
this	O
comes	O
at	O
the	O
cost	O
of	O
a	O
very	O
high	O
number	O
of	O
total	O
predicted	O
pairs	O
).	O

When	O
comparing	O
running	O
times	O
,	O
our	O
tool	O
noticeably	O
outperformed	O
all	O
the	O
other	O
engines	O
,	O
this	O
in	O
spite	O
of	O
keeping	O
up	O
competitive	O
sensitivity	O
and	O
total	O
number	O
of	O
predicted	O
pairs	O
.	O

Recall	O
that	O
fast	O
running	O
time	O
was	O
the	O
main	O
objective	O
for	O
developing	O
our	O
fast	O
filtration	O
.	O

Constraint	O
parameters	O
for	O
the	O
target	O
prediction	O
algorithm	O
.	O

seed	O
location	O

2	O
-	O
8	O

maximum	O
GU	O
pairs	O
in	O
seed	O

1	O


maximum	O
GU	O
pairs	O
total	O

4	O


maximal	O
number	O
of	O
mismatches	O
/	O
gaps	O

6	O


maximal	O
size	O
of	O
bulge	O
in	O
the	O
target	O

6	O


maximal	O
size	O
of	O
bulge	O
in	O
miRNA	O

6	O

A	O
comparison	O
between	O
our	O
method	O
and	O
other	O
target	O
prediction	O
tools	O
.	O

Tool	O

Total	O
number	O
of	O
predicted	O
pairsa	O

Number	O
of	O
TPpredicted	O
pairsb	O

Sensitivity	O

Running	O
time	O

miRanda	O

22	O
,	O
857	O

309	O

35	O
%	O

2	O
hours	O
and	O
42	O
minutess	O


PITA	O

28	O
,	O
032	O

661	O

75	O
%	O

5	O
hours	O
and	O
10	O
minutess	O


RNA	O
hybrid	O

43	O
,	O
693	O

731	O

83	O
%	O

31	O
minutes	O


Our	O
method	O

24	O
,	O
571	O

625	O

71	O
%	O

40	O
seconds	O

a	O
Out	O
of	O
63	O
,	O
360	O
pairs	O
.	O
b	O
Out	O
of	O
873	O
experimentally	O
verified	O
pairs	O
.	O

Stage	O
2	O
-	O
Finding	O
modules	O
-	O
the	O
enumeration	O
algorithm	O

In	O
this	O
section	O
we	O
describe	O
our	O
enumeration	O
algorithm	O
for	O
finding	O
modules	O
that	O
are	O
statistically	O
enriched	O
in	O
biological	O
processes	O
(	O
GO	O
categories	O
).	O

An	O
important	O
objective	O
in	O
our	O
study	O
is	O
to	O
ensure	O
that	O
the	O
modules	O
found	O
by	O
our	O
method	O
contain	O
miRNAs	O
that	O
are	O
mutually	O
expressed	O
and	O
thus	O
can	O
cooperatively	O
regulate	O
gene	O
expression	O
.	O

In	O
order	O
to	O
ensure	O
this	O
condition	O
,	O
we	O
use	O
the	O
miRNA	O
Atlas	O
[	O
43	O
].	O

This	O
Atlas	O
provides	O
miRNA	O
expression	O
profiles	O
in	O
different	O
conditions	O
(	O
i	O
.	O
e	O
.,	O
different	O
organ	O
systems	O
and	O
cell	O
types	O
,	O
of	O
normal	O
and	O
malignant	O
tissues	O
).	O

We	O
focus	O
on	O
a	O
set	O
of	O
conditions	O
where	O
both	O
human	B-OG
and	O
viral	O
miRNAs	O
(	O
of	O
the	O
virus	B-OG
of	O
interest	O
)	O
are	O
expressed	O
.	O

Based	O
on	O
these	O
data	O
sources	O
,	O
we	O
address	O
the	O
following	O
problem	O
.	O

Given	O
a	O
GO	O
category	O
C	O
,	O
a	O
miRNA	O
atlas	O
condition	O
A	O
,	O
expression	O
level	O
threshold	O
t	O
,	O
a	O
p	O
-	O
value	O
threshold	O
p	O
,	O
the	O
minimal	O
number	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
required	O
in	O
a	O
sought	O
module	O
q1	O
and	O
q2	O
(	O
the	O
quorums	O
),	O
respectively	O
.	O

Find	O
all	O
the	O
modules	O
composed	O
of	O
miRNAs	O
whose	O
expression	O
in	O
A	O
is	O
greater	O
than	O
t	O
,	O
which	O
include	O
at	O
least	O
q1	O
and	O
q2	O
human	B-OG
and	O
viral	O
miRNAs	O
,	O
respectively	O
,	O
and	O
whose	O
intersection	O
of	O
the	O
target	O
-	O
sets	O
of	O
human	B-OG
genes	O
yields	O
an	O
enrichment	O
p	O
-	O
value	O
smaller	O
than	O
p	O
in	O
C	O
.	O

The	O
enrichment	O
is	O
measured	O
using	O
a	O
hypergeometric	O
p	O
-	O
value	O
[	O
44	O
].	O

The	O
hypergeometric	O
p	O
-	O
value	O
measures	O
the	O
statistical	O
significance	O
of	O
the	O
overlap	O
between	O
the	O
target	O
genes	O
and	O
the	O
genes	O
in	O
the	O
considered	O
category	O
(	O
for	O
more	O
details	O
see	O
the	O
Appendix	O
Section	O
).	O

For	O
each	O
GO	O
category	O
C	O
and	O
each	O
Atlas	O
condition	O
A	O
of	O
interest	O
,	O
we	O
perform	O
the	O
enumeration	O
process	O
as	O
follows	O
.	O

Let	O
H	O
and	O
V	O
be	O
the	O
set	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
.	O

Let	O
HA	O
and	O
VA	O
be	O
the	O
subset	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
expressed	O
in	O
A	O
.	O

Let	O
TA	O
be	O
the	O
set	O
of	O
their	O
target	O
genes	O
(	O
each	O
gene	O
in	O
TA	O
is	O
targeted	O
by	O
at	O
least	O
q1	O
human	B-OG
and	O
q2	O
viral	O
miRNAs	O
);	O
and	O
let	O
TCA	O
=	O
TA	O
∩	O
C	O
(	O
see	O
Figure	O
3	O
).	O

An	O
illustration	O
of	O
the	O
connection	O
between	O
Atlas	O
condition	O
and	O
GO	O
category	O
.	O
H	O
is	O
all	O
the	O
known	O
human	B-OG
miRNAs	O
and	O
V	O
is	O
all	O
known	O
viral	O
miRNAs	O
.	O
HA	O
(	O
VA	O
)	O
are	O
the	O
human	B-OG
(	O
viral	O
)	O
miRNAs	O
expressed	O
in	O
Atlas	O
category	O
A	O
.	O

They	O
target	O
gene	O
set	O
TA	O
.	O
TCA	O
consists	O
of	O
the	O
targets	O
of	O
TA	O
that	O
belong	O
to	O
GO	O
category	O
C	O
.	O

Our	O
enumeration	O
algorithm	O
dynamically	O
constructs	O
and	O
prunes	O
an	O
enumeration	O
tree	O
,	O
which	O
is	O
built	O
from	O
the	O
genes	O
in	O
TCA	O
.	O

A	O
path	O
in	O
the	O
tree	O
represents	O
a	O
potential	O
module	O
.	O

The	O
module	O
consists	O
of	O
the	O
genes	O
in	O
the	O
inner	O
nodes	O
of	O
the	O
path	O
and	O
a	O
list	O
of	O
miRNAs	O
(	O
which	O
target	O
all	O
these	O
genes	O
)	O
in	O
the	O
leaf	O
(	O
see	O
,	O
e	O
.	O
g	O
.,	O
Figures	O
4	O
and	O
5	O
).	O

At	O
the	O
end	O
of	O
the	O
run	O
of	O
the	O
algorithm	O
,	O
the	O
enumeration	O
tree	O
stores	O
in	O
its	O
leaves	O
all	O
the	O
modules	O
that	O
satisfy	O
the	O
quorum	O
constraints	O
.	O

The	O
pseudocode	O
of	O
our	O
algorithm	O
is	O
found	O
in	O
the	O
Appendix	O
Section	O
.	O

Below	O
we	O
supply	O
an	O
illustration	O
of	O
the	O
algorithm	O
applied	O
on	O
the	O
data	O
from	O
Table	O
3	O
,	O
with	O
the	O
quorum	O
constraints	O
q1	O
=	O
2	O
and	O
q2	O
=	O
1	O
.	O

We	O
initialize	O
the	O
tree	O
to	O
consist	O
of	O
a	O
root	O
node	O
and	O
one	O
dummy	O
leaf	O
node	O
with	O
all	O
the	O
human	B-OG
and	O
viral	O
miRNAs	O
in	O
A	O
(	O
see	O
the	O
leftmost	O
leaf	O
in	O
Figure	O
4	O
(	O
a	O
)).	O

Genes	O
are	O
inserted	O
to	O
the	O
tree	O
one	O
by	O
one	O
in	O
order	O
of	O
increasing	O
number	O
of	O
hits	O
of	O
human	B-OG
miRNAs	O
on	O
the	O
gene	O
(	O
b	O
,	O
c	O
,	O
d	O
,	O
a	O
).	O

Each	O
inserted	O
gene	O
,	O
g	O
,	O
is	O
connected	O
by	O
an	O
edge	O
to	O
the	O
root	O
and	O
becomes	O
a	O
root	O
of	O
newly	O
generated	O
copies	O
of	O
all	O
its	O
preceding	O
siblings	O
in	O
the	O
tree	O
.	O

The	O
leaves	O
of	O
the	O
new	O
subtree	O
contain	O
intersections	O
of	O
g	O
'	O
s	O
miRNA	O
sets	O
(	O
human	B-OG
and	O
viral	O
)	O
with	O
the	O
corresponding	O
sets	O
in	O
the	O
siblings	O
'	O
leaves	O
.	O

When	O
these	O
intersections	O
do	O
not	O
satisfy	O
the	O
quorum	O
constraints	O
we	O
prune	O
the	O
unsatisfying	O
edge	O
from	O
the	O
tree	O
.	O

(	O
See	O
the	O
node	O
for	O
gene	O
b	O
,	O
and	O
then	O
for	O
gene	O
c	O
,	O
in	O
Figure	O
4	O
(	O
a	O
).	O

The	O
leaves	O
of	O
the	O
subtree	O
rooted	O
at	O
c	O
contain	O
the	O
intersections	O
of	O
the	O
set	O
of	O
miRNAs	O
hitting	O
c	O
with	O
the	O
set	O
of	O
the	O
dummy	O
leaf	O
,	O
and	O
of	O
b	O
.	O

Notice	O
that	O
the	O
respective	O
intersections	O
of	O
the	O
miRNA	O
sets	O
hitting	O
b	O
and	O
c	O
are	O
empty	O
.	O

Thus	O
the	O
edge	O
from	O
c	O
to	O
b	O
is	O
pruned	O
from	O
the	O
tree	O
).	O

miRNA	O
target	O
information	O
.	O

Genes	O
miRNAs	O

a	O

b	O

c	O

d	O

human	B-OG
-	O
miR	O
-	O
1	O

√	O

√	O


human	B-OG
-	O
miR	O
-	O
2	O

√	O

√	O


human	B-OG
-	O
miR	O
-	O
3	O

√	O

√	O


human	B-OG
-	O
miR	O
-	O
4	O

√	O

√	O


human	B-OG
-	O
miR	O
-	O
5	O

√	O

√	O


human	B-OG
-	O
miR	O
-	O
6	O

√	O

√	O


viral	O
-	O
miR	O
-	O
A	O

√	O

√	O


viral	O
-	O
miR	O
-	O
B	O

√	O

√	O


total	O
human	B-OG
miRNAs	O

1	O
,	O
2	O
,	O
4	O
,	O
6	O

3	O
,	O
5	O

2	O
,	O
4	O
,	O
6	O

1	O
,	O
3	O
,	O
5	O


total	O
viral	O
miRNAs	O

A	O

B	O

A	O

B	O

The	O
columns	O
correspond	O
to	O
genes	O
(	O
in	O
TCA	O
)	O
and	O
the	O
rows	O
to	O
human	B-OG
and	O
viral	O
miRNAs	O
(	O
HA	O
and	O
VA	O
,	O
respectively	O
).	O

Cell	O
(	O
M	O
,	O
G	O
)	O
in	O
the	O
table	O
is	O
checked	O
if	O
miRNA	O
M	O
is	O
predicted	O
to	O
target	O
gene	O
G	O
.	O

The	O
last	O
row	O
provides	O
,	O
for	O
every	O
gene	O
,	O
its	O
targeting	O
miRNAs	O
(	O
numbers	O
and	O
letters	O
corresponding	O
to	O
human	B-OG
and	O
viral	O
miRNAs	O
,	O
respectively	O
).	O

The	O
process	O
of	O
building	O
the	O
enumeration	O
tree	O
for	O
target	O
information	O
in	O
Table	O
3	O
.	O

The	O
rhombus	O
represents	O
the	O
root	O
of	O
the	O
tree	O
.	O

The	O
circles	O
represent	O
the	O
genes	O
inserted	O
into	O
the	O
tree	O
.	O

The	O
squares	O
represent	O
the	O
leaves	O
,	O
which	O
store	O
two	O
sets	O
of	O
miRNAs	O
-	O
human	B-OG
and	O
viral	O
.	O

These	O
miRNAs	O
are	O
common	O
""""	O
targeters	O
""""	O
to	O
all	O
the	O
genes	O
in	O
the	O
path	O
from	O
the	O
leaf	O
to	O
the	O
root	O
.	O

Viral	O
miRNAs	O
are	O
labeled	O
with	O
uppercase	O
letters	O
and	O
the	O
human	B-OG
miRNAs	O
are	O
labeled	O
with	O
numbers	O
.	O

The	O
rectangles	O
indicate	O
modules	O
that	O
are	O
pruned	O
from	O
the	O
tree	O
for	O
one	O
of	O
two	O
reasons	O
:	O
(	O
1	O
)	O
modules	O
that	O
break	O
the	O
quorum	O
are	O
in	O
solid	O
rectangles	O
(	O
in	O
this	O
example	O
the	O
required	O
quorum	O
is	O
1	O
viral	O
miRNA	O
and	O
2	O
human	B-OG
miRNAs	O
);	O
(	O
2	O
)	O
redundant	O
modules	O
(	O
which	O
are	O
fully	O
contained	O
in	O
another	O
module	O
)	O
are	O
in	O
dotted	O
rectangles	O
.	O

The	O
arrow	O
indicates	O
the	O
containment	O
,	O
starting	O
from	O
the	O
redundant	O
module	O
and	O
ending	O
in	O
the	O
bigger	O
one	O
.	O

The	O
three	O
sub	O
-	O
figures	O
(	O
a	O
),	O
(	O
b	O
),	O
and	O
(	O
c	O
)	O
show	O
the	O
insertion	O
of	O
genes	O
b	O
and	O
c	O
,	O
d	O
,	O
and	O
a	O
into	O
the	O
tree	O
,	O
respectively	O
.	O

The	O
final	O
enumeration	O
tree	O
.	O

The	O
modules	O
found	O
by	O
the	O
enumeration	O
algorithm	O
(	O
encircled	O
by	O
ellipses	O
).	O

In	O
Figure	O
4	O
(	O
b	O
)	O
we	O
show	O
the	O
tree	O
after	O
inserting	O
d	O
and	O
making	O
it	O
the	O
root	O
of	O
all	O
its	O
preceding	O
siblings	O
:	O
the	O
dummy	O
node	O
,	O
b	O
node	O
,	O
and	O
c	O
node	O
.	O

In	O
the	O
leaves	O
of	O
the	O
subtree	O
rooted	O
at	O
d	O
are	O
the	O
intersections	O
of	O
the	O
respective	O
miRNA	O
sets	O
.	O

Now	O
two	O
prunings	O
occur	O
in	O
the	O
enumeration	O
tree	O
.	O

The	O
original	O
node	O
b	O
(	O
in	O
the	O
dotted	O
rectangle	O
)	O
and	O
its	O
targeting	O
miRNAs	O
,	O
are	O
now	O
fully	O
contained	O
in	O
the	O
subtree	O
rooted	O
in	O
d	O
,	O
thus	O
b	O
is	O
now	O
redundant	O
and	O
deleted	O
from	O
the	O
enumeration	O
tree	O
.	O

As	O
in	O
4	O
(	O
a	O
),	O
the	O
sets	O
of	O
miRNAs	O
of	O
c	O
and	O
of	O
d	O
are	O
both	O
empty	O
and	O
the	O
edge	O
from	O
d	O
to	O
c	O
is	O
pruned	O
(	O
solid	O
rectangle	O
).	O

In	O
Figure	O
4	O
(	O
c	O
)	O
we	O
illustrate	O
adding	O
a	O
,	O
making	O
it	O
the	O
root	O
of	O
the	O
subtrees	O
of	O
its	O
siblings	O
.	O

Intersecting	O
a	O
'	O
s	O
miRNA	O
sets	O
with	O
the	O
siblings	O
'	O
miRNA	O
sets	O
,	O
resulting	O
in	O
deleting	O
c	O
(	O
dotted	O
rectangle	O
)	O
and	O
pruning	O
d	O
(	O
solid	O
rectangle	O
).	O

At	O
the	O
end	O
of	O
the	O
process	O
,	O
the	O
enumeration	O
tree	O
contains	O
all	O
the	O
modules	O
(	O
see	O
Figure	O
5	O
).	O

The	O
leaves	O
of	O
the	O
tree	O
are	O
traversed	O
and	O
their	O
p	O
-	O
value	O
is	O
computed	O
.	O

The	O
modules	O
are	O
then	O
filtered	O
(	O
see	O
the	O
sampling	O
procedure	O
below	O
)	O
and	O
reported	O
according	O
to	O
ascending	O
p	O
-	O
value	O
.	O

The	O
sampling	O
procedure	O

To	O
set	O
a	O
cutoff	O
p	O
-	O
value	O
for	O
significant	O
modules	O
,	O
we	O
estimate	O
the	O
distribution	O
of	O
the	O
hyper	O
-	O
geometric	O
p	O
-	O
value	O
scores	O
for	O
every	O
<	O
A	O
,	O
C	O
>	O
pair	O
as	O
follows	O
.	O

We	O
sample	O
,	O
from	O
the	O
full	O
set	O
of	O
miRNAs	O
,	O
two	O
subsets	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
,	O
of	O
same	O
size	O
as	O
HA	O
and	O
VA	O
,	O
respectively	O
.	O

Then	O
we	O
find	O
their	O
target	O
genes	O
that	O
satisfy	O
the	O
quorums	O
,	O
and	O
intersect	O
them	O
with	O
C	O
.	O

Next	O
,	O
we	O
perform	O
the	O
enumeration	O
algorithm	O
on	O
the	O
genes	O
in	O
the	O
intersection	O
and	O
store	O
the	O
hypergeometric	O
p	O
-	O
values	O
of	O
the	O
obtained	O
modules	O
.	O

We	O
repeat	O
this	O
sampling	O
process	O
10	O
,	O
000	O
times	O
,	O
and	O
compute	O
the	O
distribution	O
of	O
the	O
obtained	O
p	O
-	O
values	O
.	O

This	O
distribution	O
allows	O
us	O
to	O
pick	O
a	O
significant	O
p	O
-	O
value	O
for	O
our	O
reported	O
modules	O
.	O

We	O
pick	O
the	O
p	O
-	O
value	O
that	O
is	O
in	O
the	O
0	O
.	O
01	O
quantile	O
of	O
the	O
distribution	O
to	O
be	O
the	O
p	O
-	O
value	O
cutoff	O
for	O
our	O
reported	O
modules	O
.	O

Results	O

We	O
applied	O
our	O
system	O
to	O
the	O
discovery	O
of	O
modules	O
of	O
genes	O
targeted	O
by	O
human	B-OG
miRNAs	O
and	O
miRNAs	O
of	O
the	O
Epstein	B-OG
Barr	I-OG
Virus	I-OG
.	O

The	O
Epstein	B-OG
-	I-OG
Barr	I-OG
virus	I-OG
(	O
EBV	B-OG
)	O
is	O
a	O
human	B-OG
herpes	I-OG
-	I-OG
virus	I-OG
that	O
infects	O
over	O
90	O
%	O
of	O
the	O
human	B-OG
population	O
worldwide	O
.	O

EBV	B-OG
can	O
infect	O
B	O
lymphocytes	O
and	O
epithelial	O
cells	O
,	O
and	O
typically	O
establishes	O
long	O
-	O
term	O
asymptomatic	O
latent	B-DS
infection	I-DS
in	O
memory	O
B	O
lymphocytes	O
.	O

Nevertheless	O
,	O
EBV	B-DS
infection	I-DS
has	O
oncogenic	O
potential	O
,	O
which	O
can	O
result	O
in	O
a	O
number	O
of	O
malignancies	O
,	O
including	O
Burkitt	B-DS
'	I-DS
s	I-DS
lymphoma	I-DS
,	O
Hodgkin	B-DS
'	I-DS
s	I-DS
lymphoma	I-DS
,	O
nasopharyngeal	B-DS
carcinoma	I-DS
,	O
and	O
lymphoproliferative	B-DS
diseases	I-DS
,	O
especially	O
among	O
immunocompromised	O
individuals	O
[	O
45	O
].	O

During	O
the	O
latent	B-DS
infection	I-DS
of	O
EBV	B-OG
,	O
only	O
a	O
limited	O
subset	O
of	O
its	O
genes	O
is	O
transcribed	O
,	O
allowing	O
it	O
to	O
evade	O
immune	O
recognition	O
.	O

Latency	O
gene	O
expression	O
is	O
classified	O
into	O
three	O
groups	O
:	O
type	O
I	O
-	O
expressing	O
only	O
nuclear	B-GP
protein	I-GP
EBNA1	B-GP
;	O
type	O
II	O
-	O
expression	O
of	O
EBNA1	B-GP
and	O
membrane	B-GP
proteins	I-GP
LMP	B-GP
-	I-GP
1	I-GP
,	O
2A	O
,	O
2B	O
;	O
type	O
III	O
-	O
six	O
nuclear	O
proteins	O
EBNA	B-GP
-	I-GP
1	I-GP
,	O
2	O
,	O
3A	O
,	O
3B	O
,	O
3C	O
,	O
LP	O
,	O
and	O
three	O
membrane	B-GP
proteins	I-GP
LMP	B-GP
-	I-GP
1	I-GP
,	O
2A	O
,	O
2B	O
.	O

The	O
noncoding	O
RNAs	O
EBER1	O
and	O
EBER2	O
and	O
a	O
set	O
of	O
EBV	B-OG
-	O
encoded	O
miRNAs	O
are	O
differentially	O
expressed	O
in	O
all	O
three	O
forms	O
of	O
latency	O
[	O
46	O
].	O

Datasets	O

The	O
set	O
of	O
human	B-OG
and	O
viral	O
mature	O
miRNA	O
sequences	O
was	O
downloaded	O
from	O
the	O
miRNA	O
registry	O
[	O
47	O
]	O
containing	O
866	O
human	B-OG
miRNAs	O
and	O
39	O
EBV	B-OG
miRNAs	O
(	O
mature	O
sequences	O
).	O

The	O
set	O
of	O
human	B-OG
3	O
'	O
UTR	O
sequences	O
was	O
extracted	O
from	O
the	O
Ensembl	O
'	O
s	O
Biomart	O
[	O
42	O
],	O
database	O
Ensembl	O
53	O
.	O

Each	O
3	O
'	O
UTR	O
in	O
this	O
set	O
is	O
annotated	O
with	O
an	O
Ensembl	O
gene	O
and	O
transcript	O
ID	O
.	O

The	O
gene	O
ontology	O
(	O
GO	O
)	O
associations	O
and	O
ontology	O
structure	O
files	O
were	O
downloaded	O
from	O
[	O
48	O
].	O

Each	O
3	O
'	O
UTR	O
was	O
attributed	O
to	O
the	O
corresponding	O
gene	O
name	O
in	O
the	O
ontology	O
file	O
,	O
using	O
the	O
Ensembl	O
gene	O
and	O
transcipt	O
IDs	O
.	O

The	O
set	O
of	O
3	O
'	O
UTRs	O
was	O
filtered	O
to	O
contain	O
3	O
'	O
UTRs	O
from	O
genes	O
that	O
are	O
expressed	O
in	O
B	O
cells	O
(	O
data	O
taken	O
from	O
Ensembl	O
Biomart	O
)	O
and	O
that	O
have	O
at	O
least	O
one	O
biological	O
process	O
annotation	O
.	O

This	O
resulted	O
in	O
7208	O
sequences	O
(	O
different	O
transcripts	O
)	O
from	O
4773	O
genes	O
.	O

UTRs	O
longer	O
than	O
3000	O
nts	O
,	O
were	O
shortened	O
to	O
3000	O
nts	O
.	O

miRNA	O
expressions	O
were	O
taken	O
from	O
the	O
miRNA	O
Atlas	O
.	O

Eight	O
tissue	O
samples	O
from	O
the	O
Atlas	O
,	O
expressing	O
both	O
human	B-OG
and	O
EBV	B-OG
miRNAs	O
,	O
were	O
found	O
to	O
be	O
relevant	O
.	O

Seventy	O
-	O
two	O
GO	O
categories	O
(	O
that	O
contain	O
10	O
-	O
300	O
genes	O
)	O
related	O
to	O
apoptosis	O
,	O
immune	O
response	O
,	O
signal	O
transduction	O
,	O
proliferation	O
,	O
and	O
cell	O
cycle	O
were	O
chosen	O
.	O

The	O
target	O
prediction	O
stage	O

In	O
the	O
first	O
stage	O
we	O
ran	O
all	O
-	O
against	O
-	O
all	O
target	O
prediction	O
between	O
the	O
miRNA	O
and	O
3	O
'	O
UTR	O
sets	O
described	O
above	O
.	O

The	O
target	O
prediction	O
was	O
carried	O
out	O
with	O
the	O
constraints	O
listed	O
in	O
Table	O
1	O
,	O
which	O
are	O
derived	O
from	O
the	O
literature	O
(	O
e	O
.	O
g	O
.	O
[	O
12	O
,	O
22	O
,	O
49	O
]).	O

In	O
addition	O
we	O
checked	O
duplex	O
energy	O
at	O
the	O
leaves	O
of	O
the	O
prefix	O
tree	O
(	O
see	O
Methods	O
).	O

The	O
duplex	O
energy	O
was	O
normalized	O
by	O
the	O
energy	O
of	O
the	O
duplex	O
formed	O
between	O
the	O
miRNA	O
and	O
its	O
complement	O
,	O
and	O
if	O
the	O
resulting	O
ratio	O
exceeded	O
a	O
threshold	O
of	O
0	O
.	O
4	O
the	O
target	O
prediction	O
was	O
accepted	O
as	O
positive	O
.	O

Running	O
the	O
target	O
prediction	O
on	O
866	O
human	B-OG
miRNAs	O
(	O
39	O
EBV	B-OG
miRNAs	O
)	O
and	O
7208	O
human	B-OG
mRNAs	O
(	O
3	O
'	O
UTRs	O
)	O
resulted	O
in	O
283362	O
human	B-OG
miRNA	O
/	O
human	B-OG
mRNAs	O
(	O
11663	O
EBV	B-OG
miRNA	O
/	O
human	B-OG
mRNAs	O
)	O
pairs	O
.	O

We	O
analyzed	O
some	O
characteristics	O
of	O
the	O
putative	O
target	O
-	O
binding	O
association	O
(	O
for	O
the	O
human	B-OG
miRNA	O
-	O
mRNA	O
pairs	O
).	O

Figure	O
6	O
(	O
a	O
)	O
shows	O
the	O
distribution	O
of	O
the	O
number	O
of	O
target	O
mRNAs	O
per	O
each	O
human	B-OG
miRNA	O
,	O
and	O
Figure	O
6	O
(	O
b	O
)	O
shows	O
distribution	O
of	O
the	O
number	O
of	O
human	B-OG
miRNAs	O
targeting	O
each	O
mRNA	O
.	O

According	O
to	O
this	O
analysis	O
,	O
one	O
human	B-OG
miRNA	O
binds	O
putatively	O
to	O
the	O
3	O
'	O
UTR	O
of	O
327	O
mRNAs	O
on	O
average	O
(	O
4	O
.	O
5	O
%	O
of	O
the	O
total	O
number	O
of	O
mRNAs	O
in	O
the	O
dataset	O
).	O

Alternatively	O
,	O
one	O
mRNA	O
is	O
targeted	O
by	O
39	O
human	B-OG
miRNAs	O
on	O
average	O
(	O
4	O
.	O
5	O
%	O
of	O
the	O
total	O
number	O
of	O
human	B-OG
miRNAs	O
in	O
the	O
dataset	O
).	O

An	O
analysis	O
of	O
the	O
efficiency	O
of	O
our	O
filter	O
can	O
be	O
found	O
in	O
the	O
Appendix	O
Section	O
.	O

Characteristics	O
of	O
the	O
human	B-OG
miRNAs	O
/	O
human	B-OG
mRNAs	O
relationships	O
.	O

(	O
a	O
)	O
Distribution	O
of	O
the	O
number	O
of	O
target	O
mRNAs	O
per	O
each	O
miRNA	O
.	O

(	O
b	O
)	O
Distribution	O
of	O
the	O
number	O
of	O
miRNAs	O
targeting	O
each	O
mRNA	O
.	O

The	O
predicted	O
modules	O
and	O
supporting	O
evidence	O

In	O
this	O
stage	O
we	O
used	O
the	O
target	O
prediction	O
results	O
from	O
the	O
previous	O
stage	O
.	O

The	O
enumeration	O
process	O
was	O
carried	O
out	O
on	O
72	O
GO	O
categories	O
versus	O
8	O
Atlas	O
conditions	O
,	O
resulting	O
in	O
576	O
<	O
A	O
,	O
C	O
>	O
pairs	O
,	O
where	O
A	O
denotes	O
an	O
Atlas	O
condition	O
and	O
C	O
denotes	O
a	O
GO	O
category	O
.	O

We	O
found	O
54	O
modules	O
that	O
fulfilled	O
the	O
following	O
quorum	O
constraints	O
,	O
q1	O
=	O
2	O
,	O
q2	O
=	O
1	O
,	O
and	O
had	O
a	O
p	O
-	O
value	O
lower	O
than	O
the	O
cutoff	O
(	O
obtained	O
by	O
a	O
sampling	O
procedure	O
for	O
each	O
such	O
pair	O
.	O

See	O
Methods	O
for	O
details	O
).	O

Modules	O
with	O
fewer	O
than	O
two	O
genes	O
were	O
filtered	O
out	O
.	O

The	O
expression	O
level	O
threshold	O
t	O
was	O
calculated	O
for	O
each	O
miRNA	O
as	O
the	O
average	O
expression	O
among	O
all	O
the	O
Atlas	O
conditions	O
related	O
to	O
B	O
cells	O
.	O

Among	O
the	O
GO	O
categories	O
tested	O
in	O
our	O
experiment	O
,	O
there	O
are	O
dependent	O
categories	O
that	O
contain	O
the	O
same	O
genes	O
.	O

Among	O
Atlas	O
conditions	O
sometimes	O
groups	O
of	O
expressed	O
miRNAs	O
overlap	O
.	O

In	O
order	O
to	O
reduce	O
the	O
redundancy	O
of	O
the	O
reported	O
modules	O
we	O
combined	O
identical	O
modules	O
from	O
different	O
GO	O
categories	O
and	O
Atlas	O
conditions	O
.	O

This	O
procedure	O
resulted	O
in	O
34	O
modules	O
.	O

Below	O
we	O
present	O
and	O
analyze	O
two	O
selected	O
modules	O
that	O
were	O
found	O
by	O
our	O
method	O
.	O

The	O
full	O
set	O
of	O
potential	O
modules	O
can	O
be	O
obtained	O
at	O
http	O
://	O
www	O
.	O
cs	O
.	O
bgu	O
.	O
ac	O
.	O
il	O
/~	O
vaksler	O
/	O
BiTargeting	O
.	O
htm	O
.	O

Module	O
I	O
(	O
see	O
Figure	O
7	O
(	O
a	O
))	O
was	O
obtained	O
from	O
genes	O
related	O
to	O
""""	O
induction	O
of	O
apoptosis	O
""""	O
and	O
miRNAs	O
that	O
are	O
expressed	O
in	O
Burkitt	B-DS
lymphoma	I-DS
.	O

The	O
module	O
consists	O
of	O
three	O
human	B-OG
miRNAs	O
,	O
miR	O
-	O
17	O
,	O
miR	O
-	O
20a	O
,	O
and	O
miR	O
-	O
15b	O
,	O
one	O
viral	O
miRNA	O
,	O
miR	O
-	O
BART5	O
,	O
and	O
three	O
human	B-OG
genes	O
.	O

A	O
thorough	O
literature	O
search	O
supported	O
our	O
predictions	O
as	O
follows	O
.	O

miR	O
-	O
17	O
and	O
miR	O
-	O
20a	O
belong	O
to	O
the	O
genomic	O
cluster	O
miR	O
-	O
17	O
-	O
92	O
.	O

The	O
cluster	O
consists	O
of	O
six	O
miRNAs	O
that	O
are	O
tightly	O
grouped	O
within	O
an	O
800	O
base	O
-	O
pair	O
region	O
of	O
human	B-OG
chromosome	O
13	O
[	O
50	O
].	O

The	O
miR	O
-	O
17	O
-	O
92	O
cluster	O
first	O
attracted	O
attention	O
following	O
a	O
series	O
of	O
observations	O
linking	O
these	O
miRNAs	O
to	O
cancer	B-DS
pathogenesis	O
,	O
as	O
it	O
undergoes	O
amplification	O
in	O
several	O
types	O
of	O
lymphoma	B-DS
and	O
solid	B-DS
tumors	I-DS
.	O

It	O
was	O
also	O
shown	O
that	O
these	O
miRNAs	O
are	O
tightly	O
linked	O
to	O
the	O
functions	O
of	O
the	O
E2F	B-GP
family	O
of	O
transcription	B-GP
factors	I-GP
,	O
which	O
are	O
critical	O
regulators	O
of	O
the	O
cell	O
cycle	O
and	O
apoptosis	O
.	O

Furthermore	O
,	O
O	O
'	O
Donnell	O
et	O
al	O
.	O
[	O
51	O
]	O
validated	O
that	O
E2F1	B-GP
is	O
a	O
target	O
of	O
miR	O
-	O
17	O
and	O
miR	O
-	O
20a	O
.	O

Therefore	O
,	O
these	O
miRNAs	O
lead	O
to	O
decreased	O
E2F1	B-GP
protein	O
and	O
thus	O
attenuate	O
E2F	B-GP
induced	O
apoptosis	O
(	O
see	O
Figure	O
8	O
).	O

Two	O
predicted	O
modules	O
.	O

The	O
length	O
of	O
the	O
UTR	O
is	O
indicated	O
in	O
the	O
parentheses	O
near	O
the	O
gene	O
name	O
.	O

The	O
expression	O
in	O
the	O
Atlas	O
condition	O
and	O
the	O
average	O
expression	O
among	O
B	O
cell	O
conditions	O
is	O
indicated	O
in	O
the	O
parentheses	O
under	O
the	O
miRNA	O
name	O
.	O

The	O
Atlas	O
conditions	O
:	O
(	O
a	O
)	O
has_Burkitt	O
-	O
DG	O
-	O
75	O
:	O
Burkitt	B-DS
lymphoma	I-DS
cell	O
line	O
established	O
from	O
a	O
10	O
-	O
year	O
-	O
old	O
boy	O
,	O
EBV	B-OG
+;	O
(	O
b	O
)	O
hsa_Hodgkin	O
-	O
L591	O
:	O
Hodgkin	B-DS
Lymphoma	I-DS
cell	O
line	O
,	O
EBV	B-OG
+.	O

The	O
function	O
of	O
Module	O
I	O
genes	O
in	O
cellular	O
apoptotic	O
pathways	O
,	O
and	O
the	O
cooperative	O
role	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
in	O
this	O
cascade	O
.	O

The	O
dashed	O
arrows	O
indicate	O
validated	O
targets	O
of	O
the	O
miRNAs	O
,	O
the	O
solid	O
arrows	O
indicate	O
the	O
new	O
regulation	O
pattern	O
discovered	O
in	O
our	O
module	O
(	O
the	O
figure	O
is	O
partially	O
adopted	O
from	O
[	O
56	O
]).	O

The	O
third	O
human	B-OG
miRNA	O
is	O
miR	O
-	O
15b	O
.	O

This	O
miRNA	O
was	O
recently	O
shown	O
to	O
regulate	O
cell	O
cycle	O
progression	O
in	O
glioma	B-DS
cells	O
by	O
targeting	O
cell	O
cycle	O
-	O
related	O
genes	O
,	O
such	O
as	O
CCNE1	B-GP
[	O
52	O
].	O

In	O
addition	O
,	O
Cimmino	O
et	O
al	O
.	O
[	O
53	O
]	O
reported	O
that	O
its	O
analog	O
miR	O
-	O
15a	O
(	O
along	O
with	O
miR	O
-	O
16	O
-	O
1	O
)	O
negatively	O
regulates	O
BCL2	B-GP
,	O
which	O
is	O
an	O
anti	O
-	O
apoptotic	O
gene	O
that	O
is	O
often	O
overexpressed	O
in	O
many	O
types	O
of	O
human	B-OG
cancers	B-DS
.	O

The	O
participation	O
of	O
this	O
miRNA	O
in	O
this	O
module	O
suggests	O
that	O
this	O
miRNA	O
may	O
also	O
have	O
oncogenic	O
roles	O
in	O
this	O
particular	O
type	O
of	O
malignancy	O
,	O
by	O
targeting	O
genes	O
that	O
promote	O
apoptosis	O
.	O

The	O
viral	O
miRNA	O
miR	O
-	O
BART5	O
was	O
shown	O
to	O
target	O
a	O
human	B-OG
protein	O
PUMA	B-GP
[	O
54	O
].	O

PUMA	B-GP
plays	O
a	O
role	O
in	O
apoptosis	O
as	O
a	O
direct	O
downstream	O
target	O
of	O
p53	B-GP
,	O
in	O
addition	O
to	O
being	O
able	O
to	O
initiate	O
apoptosis	O
via	O
a	O
p53	B-GP
-	O
independent	O
mechanism	O
[	O
55	O
].	O

Down	O
-	O
regulation	O
of	O
PUMA	B-GP
by	O
miR	O
-	O
BART5	O
may	O
protect	O
EBV	B-OG
-	O
infected	O
cells	O
from	O
virus	B-OG
-	O
induced	O
apoptosis	O
.	O

Furthermore	O
,	O
searching	O
for	O
targets	O
of	O
BART5	O
on	O
the	O
viral	O
genome	O
revealed	O
8	O
hits	O
on	O
the	O
EBNA	B-GP
-	I-GP
LP	I-GP
protein	O
.	O

EBNA	B-GP
-	I-GP
LP	I-GP
promotes	O
the	O
expression	O
of	O
viral	O
genes	O
that	O
expose	O
the	O
virus	B-OG
to	O
the	O
immune	O
system	O
.	O

Three	O
human	B-OG
genes	O
that	O
were	O
found	O
to	O
participate	O
in	O
this	O
module	O
are	O
strongly	O
related	O
to	O
apoptosis	O
.	O

PPP1R13B	B-GP
(	O
also	O
known	O
as	O
ASPP1	B-GP
)	O
has	O
an	O
important	O
function	O
in	O
cellular	O
apoptotic	O
pathways	O
[	O
56	O
,	O
57	O
].	O

ASPP1	B-GP
and	O
ASPP2	B-GP
(	O
another	O
member	O
of	O
ASPP	B-GP
family	O
)	O
are	O
induced	O
by	O
the	O
E2F1	B-GP
transcription	B-GP
factor	I-GP
and	O
cooperate	O
with	O
the	O
tumor	B-GP
suppressor	I-GP
p53	I-GP
and	O
its	O
family	O
members	O
p63	B-GP
and	O
p73	B-GP
in	O
trans	O
-	O
activating	O
pro	O
-	O
apoptotic	O
genes	O
such	O
as	O
the	O
BCL2	B-GP
-	O
family	O
member	O
BAX	B-GP
,	O
the	O
BCL2	B-GP
-	O
binding	O
component	O
PUMA	B-GP
,	O
and	O
p53	B-GP
-	I-GP
induced	I-GP
gene	I-GP
3	I-GP
(	O
PIG3	B-GP
)	O
(	O
see	O
Figure	O
8	O
).	O

Inhibition	O
of	O
endogenous	O
ASPP	B-GP
function	O
suppresses	O
the	O
apoptotic	O
function	O
of	O
endogenous	O
p53	B-GP
in	O
response	O
to	O
apoptotic	O
stimuli	O
[	O
57	O
].	O

The	O
second	O
gene	O
in	O
the	O
module	O
is	O
BCL2L11	B-GP
(	O
also	O
known	O
as	O
BIM	B-GP
),	O
which	O
is	O
a	O
pro	O
-	O
apoptotic	O
gene	O
that	O
regulates	O
cell	O
death	O
in	O
mature	O
B	O
cells	O
.	O

It	O
is	O
thought	O
to	O
initiate	O
apoptosis	O
by	O
binding	O
to	O
and	O
inactivating	O
pro	O
-	O
survival	O
BCL2	B-GP
-	O
family	O
members	O
,	O
such	O
as	O
BCL2	B-GP
[	O
58	O
].	O

Deletions	O
or	O
methylation	O
of	O
the	O
BIM	B-GP
locus	O
are	O
found	O
in	O
various	O
human	B-OG
B	B-DS
lymphomas	I-DS
[	O
59	O
,	O
60	O
].	O

Furthermore	O
,	O
it	O
was	O
shown	O
previously	O
that	O
latent	B-DS
infection	I-DS
of	O
Burkitt	B-DS
Lymphoma	I-DS
cells	O
with	O
EBV	B-OG
results	O
in	O
a	O
significant	O
reduction	O
in	O
the	O
expression	O
of	O
BIM	B-GP
[	O
61	O
].	O

A	O
number	O
of	O
recent	O
works	O
([	O
62	O
-	O
64	O
])	O
have	O
also	O
identified	O
BIM	B-GP
as	O
a	O
direct	O
target	O
of	O
multiple	O
members	O
of	O
the	O
miR	O
-	O
17	O
-	O
92	O
cluster	O
(	O
including	O
mir	O
-	O
17	O
and	O
miR	O
-	O
20a	O
).	O

The	O
third	O
gene	O
,	O
TP63	B-GP
(	O
also	O
known	O
as	O
p63	B-GP
),	O
an	O
important	O
epithelial	O
developmental	O
gene	O
,	O
is	O
a	O
member	O
of	O
the	O
p53	B-GP
tumor	B-DS
-	O
suppressor	O
gene	O
family	O
.	O

The	O
p63	B-GP
gene	O
has	O
two	O
promoters	O
,	O
resulting	O
in	O
two	O
different	O
types	O
of	O
proteins	O
with	O
opposing	O
functions	O
,	O
a	O
p53	B-GP
-	O
like	O
protein	O
containing	O
the	O
TA	O
domain	O
(	O
TAp63	B-GP
)	O
and	O
inhibitory	O
proteins	O
lacking	O
TA	O
,	O
called	O
DNp63	B-GP
.	O

TAp63	B-GP
upregulates	O
expression	O
of	O
proapoptotic	O
Bcl	B-GP
-	I-GP
2	I-GP
family	O
members	O
such	O
as	O
Bax	B-GP
and	O
BCL2L11	B-GP
[	O
65	O
].	O

p63	B-GP
is	O
capable	O
of	O
binding	O
a	O
series	O
of	O
p53	B-GP
-	O
responsive	O
promoters	O
and	O
can	O
transactivate	O
many	O
p53	B-GP
target	O
genes	O
.	O

p63	B-GP
activity	O
is	O
regulated	O
by	O
proteins	O
such	O
as	O
ASPP1	B-GP
and	O
ASPP2	B-GP
(	O
see	O
Figure	O
8	O
),	O
which	O
also	O
modulate	O
p53	B-GP
activity	O
.	O

p63	B-GP
can	O
mediate	O
apoptosis	O
in	O
a	O
manner	O
similar	O
to	O
that	O
of	O
p53	B-GP
,	O
and	O
it	O
was	O
proposed	O
that	O
p63	B-GP
is	O
essential	O
for	O
p53	B-GP
-	O
mediated	O
apoptosis	O
induced	O
by	O
DNA	O
damage	O
[	O
66	O
].	O

The	O
cooperative	O
regulation	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
of	O
the	O
apoptotic	O
pathway	O
is	O
demonstrated	O
in	O
Figure	O
8	O
.	O

The	O
dashed	O
arrows	O
indicate	O
validated	O
targets	O
of	O
miR	O
-	O
17	O
,	O
mir	O
-	O
20a	O
,	O
and	O
miR	O
-	O
BART5	O
,	O
and	O
the	O
solid	O
arrows	O
indicate	O
the	O
new	O
regulation	O
pattern	O
discovered	O
in	O
our	O
module	O
.	O

Our	O
predictions	O
may	O
imply	O
that	O
miRNAs	O
in	O
this	O
module	O
target	O
genes	O
along	O
the	O
cascade	O
that	O
leads	O
to	O
apoptosis	O
.	O

In	O
particular	O
,	O
these	O
results	O
predict	O
that	O
a	O
primary	O
function	O
of	O
miR	O
-	O
BART	O
-	O
5	O
may	O
be	O
to	O
prevent	O
p53	B-GP
mediated	O
apoptosis	O
by	O
targeting	O
different	O
mRNA	O
transcripts	O
.	O

Module	O
II	O
(	O
see	O
Figure	O
7	O
(	O
b	O
))	O
consists	O
of	O
miRNAs	O
from	O
the	O
Hodgkin	B-DS
Lymphoma	I-DS
cell	O
line	O
,	O
hsa	O
-	O
miR	O
-	O
17	O
,	O
hsa	O
-	O
miR	O
-	O
24	O
,	O
and	O
ebv	B-OG
-	O
miR	O
-	O
BART3	O
,	O
and	O
genes	O
from	O
the	O
""""	O
regulation	O
of	O
lymphocyte	O
activation	O
""""	O
category	O
-	O
CDKN2A	B-GP
and	O
ICOSLG	B-GP
.	O

CDKN2A	B-GP
(	O
also	O
known	O
as	O
p16	B-GP
-	I-GP
INK4A	I-GP
)	O
is	O
a	O
tumor	B-DS
suppressor	O
that	O
binds	O
to	O
the	O
complex	O
of	O
cyclin	B-GP
D1	I-GP
and	O
cyclin	B-GP
-	I-GP
dependent	I-GP
kinase	I-GP
4	I-GP
to	O
repress	O
its	O
ability	O
to	O
phosphorylate	O
the	O
retinoblastoma	B-GP
protein	I-GP
,	O
and	O
consequently	O
,	O
blocks	O
cell	O
cycle	O
progression	O
from	O
G1	O
to	O
S	O
[	O
67	O
,	O
68	O
].	O

Inactivation	O
of	O
this	O
gene	O
has	O
been	O
shown	O
in	O
a	O
wide	O
variety	O
of	O
human	B-OG
cancers	B-DS
as	O
a	O
consequence	O
of	O
mutation	O
,	O
homozygous	O
mutation	O
,	O
or	O
promoter	O
methylation	O
[	O
69	O
-	O
71	O
].	O

In	O
addition	O
,	O
it	O
was	O
shown	O
that	O
EBV	B-OG
oncoprotein	B-GP
LMP1	B-GP
blocks	O
the	O
expression	O
of	O
CDKN2A	B-GP
,	O
by	O
promoting	O
the	O
CRM1	B-GP
-	O
dependent	O
nuclear	O
export	O
of	O
Ets2	B-GP
,	O
which	O
is	O
an	O
important	O
transcription	B-GP
factor	I-GP
for	O
CDKN2A	B-GP
,	O
thereby	O
reducing	O
the	O
level	O
of	O
its	O
expression	O
[	O
72	O
].	O

Furthermore	O
,	O
human	B-OG
miRNA	O
miR	O
-	O
24	O
,	O
which	O
presents	O
in	O
this	O
module	O
,	O
has	O
been	O
demonstrated	O
to	O
promote	O
cell	O
growth	O
through	O
repression	O
of	O
this	O
gene	O
[	O
73	O
].	O

miR	O
-	O
17	O
,	O
in	O
addition	O
to	O
its	O
function	O
in	O
attenuating	O
E2F	B-GP
induced	O
apoptosis	O
(	O
see	O
module	O
I	O
),	O
was	O
shown	O
to	O
target	O
CDKN1A	B-GP
(	O
also	O
known	O
as	O
p21	B-GP
),	O
a	O
gene	O
that	O
functions	O
as	O
a	O
regulator	O
of	O
cell	O
cycle	O
progression	O
at	O
G1	O
[	O
74	O
].	O

The	O
second	O
gene	O
found	O
in	O
module	O
II	O
is	O
ICOSLG	B-GP
.	O

This	O
gene	O
is	O
expressed	O
on	O
monocytes	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
cells	O
and	O
can	O
be	O
induced	O
by	O
inflammatory	O
stimuli	O
in	O
peripheral	O
tissue	O
.	O

Binding	O
to	O
ICOSL	B-GP
delivers	O
a	O
co	O
-	O
stimulatory	O
signal	O
for	O
T	O
cell	O
proliferation	O
and	O
cytokine	B-GP
secretion	O
[	O
75	O
,	O
76	O
].	O

Furthermore	O
,	O
this	O
gene	O
was	O
shown	O
to	O
be	O
important	O
in	O
several	O
immune	O
responses	O
against	O
pathogenic	O
microorganisms	B-OG
such	O
as	O
bacteria	B-OG
,	O
parasites	O
and	O
viruses	B-OG
[	O
77	O
-	O
79	O
].	O

The	O
two	O
modules	O
presented	O
have	O
a	O
tight	O
connection	O
to	O
the	O
function	O
of	O
the	O
EBV	B-OG
,	O
which	O
establishes	O
a	O
long	O
-	O
term	O
latent	B-DS
infection	I-DS
in	O
the	O
host	O
cells	O
.	O

Thus	O
,	O
it	O
is	O
reasonable	O
to	O
assume	O
that	O
EBV	B-OG
will	O
use	O
its	O
and	O
the	O
host	O
'	O
s	O
machinery	O
,	O
including	O
miRNAs	O
,	O
for	O
downregulating	O
genes	O
that	O
lead	O
to	O
apoptosis	O
or	O
immune	O
response	O
.	O

These	O
modules	O
supply	O
evidence	O
of	O
the	O
cooperation	O
between	O
human	B-OG
and	O
EBV	B-OG
miRNAs	O
in	O
the	O
task	O
of	O
preventing	O
apoptosis	O
,	O
promoting	O
cell	O
growth	O
,	O
and	O
evading	O
the	O
immune	O
response	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
the	O
target	O
sites	O
of	O
the	O
human	B-OG
and	O
viral	O
miRNAs	O
on	O
the	O
UTRs	O
of	O
the	O
genes	O
in	O
this	O
module	O
are	O
different	O
.	O

Thus	O
this	O
cooperation	O
,	O
with	O
multiple	O
target	O
sites	O
,	O
can	O
lead	O
to	O
an	O
increased	O
degree	O
of	O
translational	O
repression	O
.	O

Discussion	O
and	O
Conclusions	O

miRNAs	O
represent	O
a	O
class	O
of	O
molecules	O
produced	O
by	O
both	O
viruses	B-OG
and	O
their	O
hosts	O
that	O
can	O
benefit	O
either	O
the	O
virus	B-OG
or	O
the	O
host	O
,	O
depending	O
on	O
the	O
particular	O
interaction	O
.	O

Viral	O
miRNAs	O
were	O
discovered	O
only	O
recently	O
,	O
and	O
functional	O
relationships	O
between	O
viruses	B-OG
and	O
viral	O
or	O
host	O
miRNAs	O
are	O
only	O
now	O
beginning	O
to	O
be	O
elucidated	O
.	O

A	O
comprehensive	O
understanding	O
of	O
the	O
entire	O
landscape	O
of	O
the	O
miRNA	O
-	O
mediated	O
host	O
-	O
virus	B-OG
interactions	O
may	O
uncover	O
novel	O
pathways	O
that	O
promote	O
or	O
limit	O
virus	B-OG
replication	O
.	O

In	O
turn	O
,	O
this	O
knowledge	O
may	O
lead	O
towards	O
the	O
development	O
of	O
effective	O
antiviral	O
therapy	O
and	O
could	O
help	O
guide	O
drug	O
design	O
.	O

In	O
this	O
work	O
we	O
focused	O
on	O
the	O
contribution	O
of	O
viral	O
and	O
host	O
miRNAs	O
in	O
regulating	O
host	O
genes	O
,	O
and	O
thus	O
in	O
promoting	O
or	O
inhibiting	O
viral	O
replication	O
or	O
life	O
cycle	O
.	O

Our	O
method	O
searches	O
for	O
modules	O
of	O
miRNAs	O
(	O
host	O
and	O
viral	O
)	O
and	O
their	O
common	O
host	O
target	O
genes	O
that	O
are	O
involved	O
in	O
similar	O
biological	O
processes	O
.	O

Our	O
method	O
is	O
related	O
to	O
bi	O
-	O
clustering	O
methods	O
that	O
have	O
been	O
used	O
in	O
various	O
biological	O
issues	O
[	O
34	O
].	O

The	O
bi	O
-	O
clustering	O
approach	O
groups	O
rows	O
and	O
columns	O
simultaneously	O
in	O
a	O
two	O
-	O
dimensional	O
data	O
matrix	O
.	O

Alternatively	O
,	O
a	O
data	O
matrix	O
can	O
be	O
viewed	O
as	O
a	O
bipartite	O
graph	O
.	O

Previous	O
works	O
,	O
dealing	O
with	O
module	O
search	O
,	O
represent	O
one	O
set	O
of	O
nodes	O
as	O
miRNAs	O
and	O
the	O
second	O
set	O
as	O
target	O
mRNAs	O
;	O
the	O
edges	O
represent	O
target	O
relations	O
.	O

Since	O
in	O
our	O
problem	O
,	O
the	O
miRNAs	O
are	O
of	O
two	O
different	O
sources	O
(	O
viral	O
and	O
human	B-OG
),	O
we	O
cannot	O
use	O
the	O
existing	O
methods	O
of	O
bi	O
-	O
clustering	O
.	O

Instead	O
,	O
our	O
graph	O
can	O
be	O
viewed	O
as	O
a	O
two	O
-	O
sided	O
bi	O
-	O
partite	O
graph	O
,	O
and	O
the	O
goal	O
is	O
to	O
find	O
two	O
sided	O
bi	O
-	O
cliques	O
.	O

In	O
order	O
to	O
achieve	O
this	O
goal	O
,	O
we	O
developed	O
a	O
new	O
bi	O
-	O
targeting	O
algorithm	O
.	O

The	O
algorithm	O
constructs	O
an	O
enumeration	O
tree	O
of	O
human	B-OG
genes	O
that	O
are	O
targeted	O
by	O
the	O
same	O
sets	O
of	O
miRNAs	O
,	O
and	O
contains	O
the	O
modules	O
at	O
the	O
end	O
of	O
its	O
construction	O
.	O

Due	O
to	O
the	O
application	O
of	O
a	O
branch	O
and	O
bound	O
technique	O
,	O
the	O
algorithm	O
is	O
very	O
efficient	O
and	O
enables	O
,	O
within	O
a	O
practical	O
time	O
,	O
enumeration	O
of	O
all	O
possible	O
modules	O
.	O

Our	O
method	O
combines	O
a	O
variety	O
of	O
biological	O
data	O
sources	O
.	O

Genomic	O
sequences	O
were	O
used	O
for	O
the	O
target	O
prediction	O
task	O
.	O

Tissue	O
context	O
information	O
was	O
used	O
to	O
narrow	O
the	O
list	O
of	O
human	B-OG
genes	O
to	O
genes	O
that	O
are	O
expressed	O
in	O
the	O
cells	O
infected	O
by	O
the	O
virus	B-OG
of	O
interest	O
(	O
e	O
.	O
g	O
.	O
B	O
cells	O
in	O
the	O
case	O
of	O
EBV	B-OG
).	O

miRNA	O
expression	O
profiles	O
(	O
from	O
the	O
miRNA	O
atlas	O
)	O
and	O
GO	O
annotations	O
enabled	O
us	O
to	O
find	O
potential	O
modules	O
consisting	O
of	O
miRNAs	O
co	O
-	O
expressed	O
in	O
an	O
Atlas	O
condition	O
(	O
and	O
have	O
a	O
potential	O
to	O
regulate	O
cooperatively	O
a	O
group	O
of	O
genes	O
)	O
and	O
genes	O
with	O
similar	O
biological	O
function	O
from	O
a	O
GO	O
category	O
.	O

The	O
combination	O
of	O
several	O
information	O
sources	O
in	O
the	O
task	O
of	O
module	O
detection	O
minimizes	O
noise	O
and	O
errors	O
accompanying	O
each	O
information	O
source	O
,	O
resulting	O
in	O
more	O
reliable	O
results	O
.	O

In	O
addition	O
,	O
we	O
developed	O
our	O
own	O
method	O
for	O
target	O
prediction	O
,	O
which	O
extends	O
the	O
threshold	O
all	O
-	O
against	O
-	O
all	O
algorithm	O
.	O

The	O
method	O
performs	O
an	O
efficient	O
genome	O
-	O
wide	O
target	O
prediction	O
of	O
all	O
the	O
miRNAs	O
against	O
all	O
the	O
possible	O
subsequences	O
of	O
a	O
set	O
of	O
mRNAs	O
.	O

Our	O
algorithm	O
was	O
able	O
to	O
prune	O
a	O
large	O
portion	O
of	O
the	O
aligned	O
trees	O
by	O
utilizing	O
the	O
fact	O
that	O
the	O
number	O
of	O
errors	O
in	O
the	O
miRNA	O
-	O
mRNA	O
duplex	O
is	O
bounded	O
by	O
some	O
threshold	O
.	O

Note	O
that	O
the	O
two	O
methods	O
we	O
present	O
in	O
this	O
paper	O
are	O
independent	O
.	O

One	O
can	O
use	O
our	O
target	O
prediction	O
algorithm	O
as	O
an	O
efficient	O
stand	O
-	O
alone	O
target	O
prediction	O
system	O
.	O

In	O
addition	O
,	O
our	O
module	O
finding	O
method	O
can	O
use	O
any	O
source	O
of	O
target	O
information	O
,	O
produced	O
by	O
any	O
of	O
the	O
existing	O
target	O
prediction	O
tools	O
,	O
using	O
different	O
principles	O
of	O
target	O
recognition	O
.	O

The	O
method	O
can	O
also	O
be	O
applied	O
to	O
other	O
viruses	B-OG
,	O
as	O
long	O
as	O
their	O
miRNA	O
expression	O
profiles	O
are	O
available	O
(	O
along	O
with	O
human	B-OG
miRNAs	O
).	O

We	O
applied	O
our	O
method	O
to	O
the	O
discovery	O
of	O
modules	O
consisting	O
of	O
human	B-OG
and	O
viral	O
(	O
EBV	B-OG
)	O
miRNAs	O
and	O
human	B-OG
genes	O
.	O

The	O
identified	O
modules	O
display	O
meaningful	O
discoveries	O
supported	O
by	O
the	O
literature	O
.	O

Two	O
of	O
the	O
modules	O
are	O
analyzed	O
in	O
detail	O
in	O
this	O
paper	O
.	O

Since	O
not	O
much	O
is	O
known	O
about	O
the	O
function	O
of	O
viral	O
miRNAs	O
,	O
finding	O
modules	O
that	O
link	O
the	O
viral	O
miRNAs	O
and	O
the	O
human	B-OG
miRNAs	O
,	O
might	O
help	O
in	O
understanding	O
the	O
role	O
of	O
viral	O
miRNAs	O
in	O
viral	B-DS
infections	I-DS
.	O

Thus	O
the	O
method	O
developed	O
in	O
this	O
work	O
can	O
be	O
of	O
help	O
to	O
better	O
understand	O
viral	O
-	O
induced	O
diseases	O
and	O
the	O
role	O
that	O
miRNAs	O
plays	O
in	O
them	O
.	O

Authors	O
'	O
contributions	O

YSA	O
presented	O
the	O
problem	O
and	O
constraint	O
parameters	O
.	O

IVL	O
,	O
KK	O
,	O
and	O
MZU	O
developed	O
the	O
algorithms	O
.	O

IVL	O
contributed	O
to	O
code	O
development	O
and	O
data	O
analysis	O
,	O
and	O
found	O
supporting	O
evidence	O
in	O
the	O
literature	O
.	O

All	O
authors	O
drafted	O
the	O
manuscript	O
,	O
and	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Appendix	O

Predicting	O
miRNA	O
targets	O
:	O
a	O
filter	O
based	O
on	O
error	O
bounded	O
complementarity	O

We	O
perform	O
a	O
genome	O
-	O
wide	O
target	O
prediction	O
of	O
all	O
the	O
miRNAs	O
against	O
all	O
the	O
possible	O
subsequences	O
of	O
a	O
set	O
of	O
mRNAs	O
in	O
an	O
efficient	O
way	O
.	O

The	O
method	O
we	O
propose	O
extends	O
the	O
threshold	O
all	O
-	O
against	O
-	O
all	O
alignment	O
algorithm	O
[	O
37	O
,	O
38	O
].	O

All	O
-	O
against	O
-	O
all	O
alignment	O
problems	O
can	O
be	O
solved	O
using	O
dynamic	O
programming	O
and	O
suffix	O
trees	O
[	O
37	O
].	O

Sagot	O
used	O
a	O
variant	O
of	O
this	O
problem	O
to	O
extract	O
approximate	O
repeated	O
motifs	O
from	O
a	O
sequence	O
or	O
common	O
motifs	O
from	O
a	O
set	O
of	O
sequences	O
[	O
38	O
].	O

In	O
this	O
work	O
we	O
extend	O
this	O
idea	O
to	O
the	O
task	O
of	O
target	O
prediction	O
by	O
using	O
prefix	O
trees	O
(	O
tries	O
).	O

The	O
trie	O
data	O
structure	O
[	O
80	O
],	O
τ	O
,	O
allows	O
representation	O
of	O
the	O
miRNA	O
/	O
mRNA	O
sequences	O
in	O
an	O
efficient	O
way	O
.	O

The	O
tree	O
τ	O
has	O
the	O
following	O
properties	O
:	O
each	O
edge	O
of	O
τ	O
represents	O
a	O
character	O
c	O
∈	O
{	O
A	O
,	O
C	O
,	O
G	O
,	O
T	O
/	O
U	O
},	O
the	O
characters	O
represented	O
by	O
sibling	O
edges	O
are	O
distinct	O
,	O
and	O
the	O
concatenation	O
of	O
the	O
labels	O
of	O
the	O
edges	O
on	O
a	O
path	O
from	O
the	O
root	O
to	O
a	O
leaf	O
represents	O
the	O
full	O
string	O
inserted	O
in	O
the	O
tree	O
.	O

For	O
our	O
target	O
prediction	O
system	O
we	O
construct	O
two	O
tries	O
,	O
one	O
for	O
the	O
miRNA	O
sequences	O
and	O
one	O
for	O
sequence	O
segments	O
of	O
the	O
(	O
reversed	O
)	O
mRNAs	O
.	O

Next	O
,	O
we	O
apply	O
the	O
branch	O
and	O
bound	O
algorithm	O
to	O
find	O
complementarities	O
between	O
sequences	O
from	O
the	O
miRNA	O
trie	O
and	O
the	O
mRNA	O
tries	O
.	O

In	O
more	O
detail	O
,	O
construction	O
of	O
the	O
tries	O
is	O
as	O
follows	O
.	O

Let	O
M	O
be	O
a	O
set	O
of	O
m	O
miRNAs	O
,	O
and	O
let	O
G	O
denote	O
a	O
set	O
of	O
n	O
mRNA	O
sequences	O
in	O
the	O
database	O
for	O
the	O
organism	O
under	O
consideration	O
.	O

Consider	O
the	O
trees	O
in	O
Figure	O
9	O
,	O
τM	O
and	O
τG	O
,	O
which	O
represent	O
the	O
miRNA	O
and	O
mRNA	O
sequences	O
,	O
respectively	O
.	O
τM	O
is	O
built	O
from	O
the	O
miRNA	O
sequences	O
in	O
5	O
'	O
→	O
3	O
'	O
orientation	O
.	O

A	O
node	O
u	O
in	O
τM	O
keeps	O
the	O
character	O
of	O
the	O
incoming	O
edge	O
(	O
the	O
empty	O
character	O
in	O
the	O
root	O
).	O

A	O
leaf	O
node	O
,	O
which	O
corresponds	O
to	O
an	O
miRNA	O
,	O
keeps	O
in	O
addition	O
a	O
boolean	O
vector	O
V	O
(	O
u	O
)	O
initialized	O
with	O
F	O
(	O
for	O
false	O
).	O

Each	O
V	O
(	O
u	O
)	O
has	O
n	O
cells	O
,	O
one	O
for	O
each	O
mRNA	O
,	O
and	O
each	O
mRNA	O
has	O
a	O
running	O
number	O
.	O

Cell	O
i	O
in	O
V	O
(	O
u	O
)	O
indicates	O
whether	O
the	O
i	O
'	O
th	O
mRNA	O
is	O
the	O
miRNA	O
'	O
s	O
predicted	O
target	O
(	O
V	O
(	O
u	O
)	O
[	O
i	O
]	O
=	O
T	O
).	O

The	O
prefix	O
tries	O
.	O

(	O
a	O
)	O
τM	O
and	O
(	O
b	O
)	O
τG	O
,	O
miRNA	O
and	O
mRNA	O
tries	O
,	O
respectively	O
.	O

τG	O
is	O
built	O
from	O
mRNA	O
subsequences	O
,	O
which	O
are	O
produced	O
by	O
partitioning	O
the	O
mRNA	O
reversed	O
(	O
3	O
'	O
→	O
5	O
')	O
sequences	O
into	O
given	O
size	O
consecutive	O
overlapping	O
windows	O
with	O
a	O
slide	O
of	O
1	O
-	O
nt	O
.	O

The	O
partitioning	O
of	O
the	O
mRNA	O
into	O
windows	O
ensures	O
that	O
every	O
nucleotide	O
in	O
the	O
mRNA	O
will	O
be	O
examined	O
as	O
a	O
potential	O
starting	O
point	O
of	O
a	O
target	O
site	O
to	O
one	O
or	O
more	O
miRNAs	O
.	O

Since	O
the	O
mRNA	O
sequence	O
may	O
have	O
bulges	O
when	O
hybridized	O
to	O
an	O
miRNA	O
,	O
we	O
set	O
the	O
size	O
of	O
the	O
window	O
to	O
be	O
longer	O
than	O
the	O
typical	O
miRNA	O
length	O
,	O
namely	O
to	O
30	O
nucleotides	O
.	O

Each	O
node	O
in	O
τG	O
keeps	O
the	O
same	O
data	O
as	O
τM	O
.	O

It	O
also	O
has	O
a	O
list	O
of	O
all	O
mRNAs	O
for	O
which	O
the	O
path	O
from	O
the	O
root	O
of	O
τG	O
to	O
this	O
node	O
spells	O
a	O
substring	O
of	O
this	O
mRNA	O
(	O
see	O
Figure	O
9	O
(	O
b	O
)).	O

Our	O
goal	O
now	O
is	O
to	O
measure	O
the	O
complementarity	O
between	O
all	O
the	O
miRNAs	O
in	O
τM	O
and	O
the	O
mRNA	O
subsequences	O
in	O
τG	O
.	O

In	O
order	O
to	O
get	O
an	O
admissible	O
branch	O
-	O
and	O
-	O
bound	O
search	O
,	O
we	O
use	O
a	O
target	O
prediction	O
score	O
which	O
is	O
monotonic	O
with	O
respect	O
to	O
the	O
increasing	O
length	O
of	O
the	O
prefixes	O
of	O
the	O
compared	O
miRNAs	O
and	O
mRNAs	O
(	O
see	O
Figure	O
10	O
).	O

The	O
score	O
,	O
which	O
is	O
denoted	O
by	O
min_err	O
(	O
u	O
,	O
v	O
)	O
is	O
computed	O
using	O
dynamic	O
programming	O
.	O

min_err	O
monotonicity	O
property	O
.	O

The	O
score	O
min_err	O
(	O
u	O
,	O
v	O
)	O
is	O
monotone	O
with	O
respect	O
to	O
the	O
increase	O
in	O
the	O
prefix	O
length	O
of	O
the	O
miRNA	O
and	O
mRNA	O
sequences	O
.	O

The	O
dynamic	O
programming	O
table	O
DP	O

for	O
any	O
pair	O
of	O
nodes	O
(	O
u	O
,	O
v	O
),	O
u	O
∈	O
τM	O
,	O
and	O
v	O
∈	O
τG	O
,	O
DP	O
[	O
u	O
,	O
v	O
]	O
holds	O
the	O
target	O
prediction	O
score	O
between	O
the	O
prefix	O
of	O
the	O
(	O
miRNA	O
)	O
sequence	O
spelled	O
by	O
the	O
path	O
from	O
the	O
root	O
of	O
τM	O
to	O
node	O
u	O
versus	O
the	O
prefix	O
of	O
the	O
(	O
mRNA	O
)	O
sequence	O
spelled	O
by	O
the	O
path	O
from	O
the	O
root	O
of	O
τG	O
to	O
node	O
v	O
,	O
respectively	O
.	O

Let	O
u	O
'	O
be	O
the	O
parent	O
of	O
node	O
u	O
in	O
τM	O
and	O
let	O
α	O
be	O
the	O
character	O
labeling	O
the	O
edge	O
between	O
them	O
.	O

Similarly	O
,	O
let	O
v	O
'	O
be	O
the	O
parent	O
of	O
v	O
in	O
τG	O
and	O
let	O
β	O
be	O
the	O
character	O
labeling	O
the	O
edge	O
between	O
them	O
.	O

If	O
we	O
traverse	O
the	O
trees	O
in	O
pre	O
-	O
order	O
traversal	O
,	O
then	O
(	O
u	O
',	O
v	O
'),	O
(	O
u	O
',	O
v	O
),	O
and	O
(	O
u	O
,	O
v	O
')	O
are	O
computed	O
before	O
(	O
u	O
,	O
v	O
).	O

The	O
target	O
prediction	O
score	O
of	O
(	O
u	O
,	O
v	O
)	O
is	O
computed	O
using	O
the	O
recurrence	O
formula	O
given	O
below	O
:	O

where	O
miRNA_gap	O
and	O
mRNA_gap	O
are	O
penalties	O
for	O
inserting	O
a	O
gap	O
on	O
the	O
miRNA	O
side	O
of	O
the	O
duplex	O
or	O
on	O
the	O
mRNA	O
side	O
of	O
the	O
duplex	O
,	O
respectively	O
,	O
and	O
match	O
(	O
α	O
,	O
β	O
)	O
is	O
the	O
dis	O
-	O
complementarity	O
penalty	O
between	O
the	O
characters	O
α	O
and	O
β	O
(	O
equal	O
to	O
0	O
if	O
α	O
and	O
β	O
are	O
complementary	O
,	O
and	O
a	O
positive	O
score	O
otherwise	O
).	O

Note	O
that	O
mismatches	O
and	O
gaps	O
increase	O
min_err	O
.	O

Using	O
the	O
restrictions	O
on	O
miRNA	O
target	O
detection	O
based	O
on	O
sequence	O
complementarity	O
,	O
we	O
can	O
bound	O
min_err	O
with	O
a	O
threshold	O
k	O
.	O

Thus	O
,	O
an	O
mRNA	O
sequence	O
T	O
has	O
a	O
chance	O
of	O
being	O
a	O
target	O
of	O
miRNA	O
sequence	O
P	O
if	O
min_err	O
of	O
P	O
and	O
T	O
is	O
at	O
most	O
k	O
.	O

Observation	O

The	O
score	O
min_err	O
(	O
u	O
,	O
v	O
)	O
is	O
monotone	O
with	O
respect	O
to	O
an	O
increase	O
in	O
the	O
prefix	O
length	O
of	O
P	O
and	O
T	O
(	O
see	O
k	O
and	O
k	O
'	O
in	O
Figure	O
10	O
).	O

Several	O
features	O
that	O
are	O
related	O
to	O
the	O
hybridization	O
pattern	O
between	O
the	O
miRNA	O
and	O
its	O
targets	O
are	O
incorporated	O
into	O
this	O
algorithm	O
.	O

There	O
is	O
an	O
option	O
(	O
a	O
)	O
to	O
require	O
a	O
seed	O
of	O
a	O
given	O
length	O
and	O
position	O
(	O
perfect	O
complementarity	O
region	O
)	O
in	O
the	O
hybridization	O
between	O
the	O
miRNA	O
and	O
the	O
mRNA	O
,	O
(	O
b	O
)	O
to	O
restrict	O
the	O
number	O
of	O
GU	O
pairs	O
that	O
are	O
formed	O
in	O
the	O
duplex	O
,	O
and	O
(	O
c	O
)	O
to	O
restrict	O
the	O
size	O
of	O
each	O
bulge	O
formed	O
in	O
the	O
duplex	O
.	O

The	O
thresholds	O
that	O
we	O
use	O
for	O
these	O
features	O
in	O
our	O
work	O
are	O
derived	O
from	O
the	O
literature	O
describing	O
experimentally	O
verified	O
miRNA	O
targets	O
(	O
see	O
the	O
Results	O
Section	O
).	O

The	O
computation	O
of	O
min_err	O
(	O
u	O
,	O
v	O
)	O
is	O
done	O
in	O
pre	O
-	O
order	O
traversal	O
of	O
the	O
trees	O
.	O

Pruning	O
is	O
performed	O
while	O
traversing	O
the	O
mRNA	O
trie	O
.	O

The	O
calculation	O
is	O
stopped	O
at	O
each	O
node	O
v	O
of	O
τG	O
where	O
min_err	O
(	O
u	O
,	O
v	O
)	O
>	O
k	O
,	O
or	O
one	O
of	O
the	O
above	O
listed	O
restrictions	O
is	O
violated	O
.	O

When	O
the	O
algorithm	O
reaches	O
a	O
leaf	O
u	O
in	O
τM	O
,	O
it	O
updates	O
V	O
(	O
u	O
)	O
according	O
to	O
the	O
mRNA	O
sequences	O
that	O
are	O
located	O
in	O
the	O
non	O
-	O
pruned	O
nodes	O
of	O
τG	O
.	O

At	O
this	O
point	O
a	O
hybridization	O
structure	O
between	O
the	O
miRNA	O
represented	O
by	O
leaf	O
u	O
and	O
the	O
corresponding	O
mRNA	O
target	O
sequences	O
is	O
calculated	O
using	O
the	O
RNAduplex	O
program	O
[	O
39	O
].	O

Duplexes	O
with	O
a	O
normalized	O
free	O
energy	O
score	O
(	O
i	O
.	O
e	O
.,	O
the	O
duplex	O
energy	O
normalized	O
by	O
the	O
energy	O
score	O
of	O
the	O
miRNA	O
bound	O
to	O
its	O
perfect	O
complement	O
)	O
less	O
than	O
a	O
given	O
user	O
threshold	O
are	O
filtered	O
.	O

After	O
performing	O
the	O
DP	O
,	O
we	O
are	O
left	O
with	O
an	O
miRNA	O
tree	O
where	O
every	O
leaf	O
node	O
v	O
is	O
associated	O
with	O
the	O
set	O
of	O
mRNAs	O
which	O
are	O
its	O
predicted	O
targets	O
,	O
as	O
maintained	O
in	O
the	O
T	O
(	O
v	O
)	O
vector	O
.	O

We	O
note	O
that	O
the	O
filter	O
described	O
in	O
this	O
section	O
is	O
stand	O
-	O
alone	O
,	O
and	O
can	O
be	O
used	O
independently	O
on	O
other	O
species	O
with	O
different	O
parameters	O
.	O

Filter	O
efficiency	O
measurements	O

We	O
demonstrate	O
the	O
efficiency	O
of	O
applying	O
our	O
filter	O
on	O
the	O
dataset	O
,	O
described	O
in	O
the	O
Datasets	O
subsection	O
,	O
with	O
three	O
sets	O
of	O
parameters	O
as	O
detailed	O
in	O
Table	O
4	O
.	O

Each	O
UTR	O
was	O
partitioned	O
into	O
sliding	O
windows	O
of	O
size	O
30	O
nts	O
,	O
with	O
a	O
sliding	O
offset	O
of	O
1	O
nts	O
between	O
frames	O
,	O
resulting	O
in	O
7356844	O
subsequences	O
.	O

Since	O
the	O
RNAduplex	O
procedure	O
is	O
by	O
far	O
the	O
most	O
time	O
consuming	O
component	O
of	O
our	O
method	O
,	O
we	O
measured	O
the	O
efficiency	O
of	O
our	O
filter	O
in	O
terms	O
of	O
the	O
number	O
of	O
calls	O
to	O
RNAduplex	O
.	O

The	O
efficiency	O
of	O
the	O
filter	O
on	O
three	O
different	O
sets	O
of	O
parameters	O
.	O

Constraints	O

(	O
A	O
)	O
RNAduplex	O
calls	O
in	O
the	O
naive	O
method	O

(	O
B	O
)	O
RNAduplex	O
calls	O
by	O
our	O
method	O

(	O
C	O
)%	O
of	O
saved	O
calls	O


Seed	O
location	O

No	O
.	O
of	O
GU	O
pairs	O

Maximal	O
bulge	O
size	O


in	O
seed	O

total	O

on	O
miRNA	O

on	O
mRNA	O

Maximal	O
no	O
.	O
of	O
errors	O

2	O
-	O
8	O

1	O

4	O

6	O

6	O

6	O

1819306	O

1108226	O

39	O
%	O


2	O
-	O
8	O

1	O

2	O

6	O

6	O

3	O

1819306	O

140920	O

92	O
%	O


2	O
-	O
7	O

0	O

4	O

6	O

6	O

6	O

480099	O

267087	O

45	O
%	O

We	O
define	O
by	O
the	O
naive	O
method	O
a	O
method	O
that	O
calls	O
RNAduplex	O
when	O
there	O
is	O
a	O
seed	O
complementarity	O
,	O
under	O
the	O
constraints	O
of	O
seed	O
location	O
and	O
number	O
of	O
GU	O
pairs	O
in	O
the	O
seed	O
(	O
see	O
columns	O
1	O
and	O
2	O
in	O
Table	O
4	O
).	O

Columns	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
contain	O
the	O
number	O
of	O
RNAduplex	O
calls	O
for	O
the	O
naive	O
method	O
and	O
for	O
our	O
method	O
,	O
respectively	O
,	O
and	O
column	O
(	O
C	O
)	O
contains	O
the	O
percent	O
of	O
calls	O
saved	O
by	O
our	O
method	O
.	O

In	O
all	O
three	O
data	O
sets	O
there	O
is	O
a	O
great	O
reduction	O
in	O
the	O
number	O
of	O
RNAduplex	O
calls	O
.	O

The	O
middle	O
row	O
demonstrates	O
a	O
much	O
bigger	O
save	O
in	O
number	O
of	O
calls	O
by	O
our	O
method	O
.	O

This	O
is	O
mainly	O
because	O
of	O
the	O
strong	O
constraint	O
applied	O
on	O
the	O
number	O
of	O
allowed	O
errors	O
(	O
column	O
6	O
).	O

The	O
reduction	O
in	O
the	O
number	O
of	O
calls	O
to	O
RNAduplex	O
is	O
due	O
to	O
the	O
compression	O
of	O
the	O
sequences	O
of	O
both	O
miRNAs	O
and	O
mRNAs	O
into	O
prefix	O
trees	O
and	O
the	O
strong	O
pruning	O
that	O
we	O
apply	O
during	O
the	O
calculation	O
of	O
the	O
hybridization	O
score	O
,	O
accompanied	O
with	O
the	O
constraints	O
that	O
we	O
apply	O
on	O
potential	O
duplexes	O
.	O

Hypergeometric	O
p	O
-	O
value	O

For	O
a	O
given	O
module	O
obtained	O
for	O
a	O
pair	O
<	O
A	O
,	O
C	O
>,	O
the	O
hypergeometric	O
p	O
-	O
value	O
is	O
computed	O
as	O
follows	O
:	O
Let	O
n	O
be	O
the	O
total	O
number	O
of	O
genes	O
in	O
the	O
dataset	O
and	O
c	O
the	O
number	O
of	O
genes	O
that	O
belong	O
to	O
the	O
GO	O
category	O
C	O
(	O
denoted	O
as	O
N	O
and	O
C	O
in	O
Figure	O
3	O
,	O
respectively	O
).	O

Let	O
t	O
be	O
the	O
number	O
of	O
mutual	O
targets	O
of	O
the	O
miRNAs	O
in	O
the	O
module	O
and	O
tc	O
the	O
number	O
of	O
genes	O
among	O
them	O
that	O
also	O
belong	O
to	O
C	O
(	O
the	O
latter	O
is	O
the	O
result	O
of	O
the	O
enumeration	O
algorithm	O
).	O

The	O
hypergeometric	O
p	O
-	O
value	O
of	O
this	O
module	O
is	O
:	O

Pseudocode	O
of	O
the	O
enumeration	O
algorithm	O

input	O
:	O
Genes	O
-	O
list	O
of	O
genes	O
from	O
a	O
certain	O
GO	O
category	O
.	O

Every	O
gene	O
x	O
in	O
this	O
list	O
has	O
a	O
set	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
targeting	O
it	O
,	O
denoted	O
as	O
x	O
.	O
h_miRs	O
and	O
x	O
.	O
v_miRs	O
,	O
respectively	O
.	O

input	O
:	O
h_miRs	O
,	O
v_miRs	O
-	O
full	O
list	O
of	O
human	B-OG
and	O
viral	O
miRNAs	O
.	O

output	O
:	O
Enumeration	O
tree	O

root	O
←	O
new	O
Node	O
();	O

dummy	O
←	O
new	O
Node	O
();	O

dummy	O
.	O
h_miRs	O
←	O
h_miRs	O
;	O

dummy	O
.	O
v_miRs	O
←	O
v	O
miRs	O
;	O

root	O
.	O
children	O
.	O
add	O
(	O
dummy	O
);	O

foreach	O
gene	O
∈	O
Genes	O
do	O

node	O
←	O
appendSiblings	O
(	O
gene	O
);	O

root	O
.	O
children	O
.	O
add	O
(	O
node	O
);	O

end	O

Algorithm	O
1	O
:	O
construct	O
tree	O

input	O
:	O
gene	O
-	O
a	O
new	O
gene	O
to	O
be	O
inserted	O
into	O
the	O
tree	O

input	O
:	O
root	O
-	O
the	O
root	O
node	O
of	O
the	O
enumeration	O
tree	O

input	O
:	O
q1	O
,	O
q2	O
-	O
quorum	O
restriction	O
on	O
human	B-OG
and	O
viral	O
miRNAs	O

output	O
:	O
Creates	O
a	O
new	O
node	O
and	O
appends	O
to	O
it	O
(	O
as	O
its	O
children	O
)	O
all	O
its	O
siblings	O

node	O
=	O
new	O
Node	O
(	O
gene	O
);	O

foreach	O
child	O
∈	O
root	O
:	O
children	O
do	O

sibling	O
←	O
copy	O
(	O
child	O
);	O

foreach	O
leaf	O
∈	O
sibling	O
:	O
leaves	O
do	O

size1	O
←	O
leaf	O
.	O
h_miRs	O
.	O
size	O
;	O

leaf	O
.	O
h_miRs	O
←	O
Intersect	O
(	O
leaf	O
.	O
h_miRs	O
,	O
gene	O
.	O
h_miRs	O
);	O

size2	O
←	O
leaf	O
.	O
v_miRs	O
.	O
size	O
;	O

leaf	O
.	O
v_miRs	O
←	O
Intersect	O
(	O
leaf	O
.	O
v_miRs	O
;	O
gene	O
.	O
v_miRs	O
);	O

if	O
size	O
(	O
leaf	O
.	O
h_miRs	O
)	O
==	O
size1	O
and	O
size	O
(	O
leaf	O
.	O
v_miRs	O
)	O
==	O
size2	O
then	O

/*	O
Delete	O
due	O
to	O
the	O
containment	O
*/	O

Delete	O
the	O
path	O
from	O
the	O
leaf	O
in	O
child	O
subtree	O
;	O

end	O

if	O
leaf	O
.	O
h_miRs	O
.	O
size	O
<	O
q1	O
or	O
leaf	O
.	O
v_miRs	O
.	O
size	O
<	O
q2	O
then	O

/*	O
Prune	O
due	O
to	O
the	O
quorum	O
restrictions	O
*/	O

Delete	O
the	O
path	O
from	O
the	O
leaf	O
in	O
sibling	O
subtree	O
;	O

end	O

end	O

node	O
.	O
children	O
.	O
add	O
(	O
sibling	O
);	O

end	O

return	O
node	O
;	O

Algorithm	O
2	O
:	O
appendSiblings	O

